Brokers have been using virtual reality for a long time, but augmented reality, or AR, is expected to be a new trend for 2017, according to the ‘Emerging Trends in Real Estate 2017’ report published by PWC (http://dtn.fm/9ITGq). With the emergence of Pokémon Go, it became clear that augmented reality could prompt over 10 million people to leave their homes and search for digital characters. Could it somehow do the same for the real estate industry?
Despite basic AR technology having been around for some time, brokers are now using it to show tenants and potential buyers customizable experiences not seen before. The biggest change in consumer behavior came after Pokémon Go showed that AR could actually encourage people to visit new places, something the real estate industry relies upon heavily. The report explains: “Since real estate, both residential and commercial, relies upon the consumer experiencing a property—almost always in a site visit—before committing to a transaction, stimulating such a visit by a technological lure can be extremely powerful.”
However, marketing and sales are not the only things in real estate that augmented and virtual reality are transforming. Companies are now able to use these technologies as a way to better train their agents and brokers, as shown by eXp World Holdings, Inc. (OTCQB: EXPI). EXPI subsidiary eXp Realty is an agent-owned cloud brokerage that has leveraged advanced-tech systems and tools to grow rapidly on an international level.
EXPI has given agents and brokers the opportunity to work, attend classes, strategize, innovate, build teams, and collaborate through the internet, from anywhere in the world. However, the company believes that the face of the real estate industry is still changing, and that real estate professionals should always be ready to improve their approach to business.
With internet technology evolving, eXp World Holdings, Inc. knows that its consumers are equipped with more knowledge than ever before, and they no longer see as great a need to visit a traditional real estate office. This is why EXPI has created a cloud-based environment where agents are able to buy and sell homes without physical brick and mortar offices. With consumers relying less and less on these offices, EXPI is able to invest more into its services, including the training of its agents and brokers, rather than covering costs associated with facilities.
For more information, visit the company’s website at www.eXpWorldHoldings.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Tuesday, January 31, 2017
Palatin Technologies, Inc. (PTN) Takes Bremelanotide to Phase 3 Clinical Trials for Hypoactive Sexual Desire Disorder (HSDD)
Hypoactive Sexual Desire Disorder, or HSDD, is a common female sexual dysfunction where the woman feels a decrease in sexual desire and an increase in personal distress from this lack of desire. It’s a disorder affecting approximately one in 10 women, and it often leads to relationship issues. According to ‘Hypoactive Sexual Desire Disorder: A Review of Epidemiology, Biopsychology, Diagnosis, and Treatment’ (http://dtn.fm/H565a), HSDD is present in just under 9% of women aged 18 to 44, over 12% of women aged 45 to 64, and over 7% of women aged over 65.
The report continues to explain that more than half of women suffering from HSDD do not seek help from their doctors or physicians. This has been largely attributed to fear and embarrassment. Despite there being a tool called ‘The Decreased Sexual Desire Screener’, available in general practices, HSDD still remains underdetected and undertreated. However, there are also new drugs being developed for the treatment of HSDD.
In 2015, a drug called Addyi (flibanserin) was approved by the Federal Drug Administration (FDA) as the first centrally acting daily medication for HSDD. Recently, Palatin Technologies, Inc. (NYSE MKT: PTN) announced Phase 3 development of Bremelanotide. Based on the biopharmaceutical company’s findings, Bremelanotide is thought to have several distinct advantages over Addyi.
Bremelanotide has a different form of administration than Addyi. Bremelanotide can be taken as needed with an onset of efficacy in approximately 30 minutes, effective for a period of eight to 10 hours. In addition to this, the drug is not expected to have a boxed warning, unlike Addyi, which has the potential of causing hypertension and syncope in certain settings.
Bremelanotide is also not believed to interact with alcohol, or have any contraindications. On the other hand, patients taking Addyi are advised to abstain from alcohol and the drug is not to be used with strong CYP3A4 or in patients with hepatic impairments, as this could increase the risk of hypertension and syncope.
The Phase 2B clinical trials involved 327 female patients, some taking Bremelanotide and others a placebo, at home, for a 20-week period. All patients suffered from some form of female sexual dysfunction. The results showed a 50% increase in Satisfying Sexual Events (SSEs) with Bremelanotide, compared to a 12% increase with placebo. Other factors that improved included an improvement in overall sexual function and a decrease in personal distress from the sexual dysfunction.
Currently, PTN’s Bremelanotide is in Phase 3 development as a treatment for hypoactive sexual desire disorder in premenopausal women. The pivotal Phase 3 clinical trials were initiated in December 2014 and January 2015, respectively, with the efficacy portion completed back in August 2016. The topline data for the drug is expected to be available in the fourth quarter of 2016. If the data is positive, the data will support an NDA filing in 2H2017 and potential NDA approval in 2H2018.
For more information, visit www.Palatin.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
The report continues to explain that more than half of women suffering from HSDD do not seek help from their doctors or physicians. This has been largely attributed to fear and embarrassment. Despite there being a tool called ‘The Decreased Sexual Desire Screener’, available in general practices, HSDD still remains underdetected and undertreated. However, there are also new drugs being developed for the treatment of HSDD.
In 2015, a drug called Addyi (flibanserin) was approved by the Federal Drug Administration (FDA) as the first centrally acting daily medication for HSDD. Recently, Palatin Technologies, Inc. (NYSE MKT: PTN) announced Phase 3 development of Bremelanotide. Based on the biopharmaceutical company’s findings, Bremelanotide is thought to have several distinct advantages over Addyi.
Bremelanotide has a different form of administration than Addyi. Bremelanotide can be taken as needed with an onset of efficacy in approximately 30 minutes, effective for a period of eight to 10 hours. In addition to this, the drug is not expected to have a boxed warning, unlike Addyi, which has the potential of causing hypertension and syncope in certain settings.
Bremelanotide is also not believed to interact with alcohol, or have any contraindications. On the other hand, patients taking Addyi are advised to abstain from alcohol and the drug is not to be used with strong CYP3A4 or in patients with hepatic impairments, as this could increase the risk of hypertension and syncope.
The Phase 2B clinical trials involved 327 female patients, some taking Bremelanotide and others a placebo, at home, for a 20-week period. All patients suffered from some form of female sexual dysfunction. The results showed a 50% increase in Satisfying Sexual Events (SSEs) with Bremelanotide, compared to a 12% increase with placebo. Other factors that improved included an improvement in overall sexual function and a decrease in personal distress from the sexual dysfunction.
Currently, PTN’s Bremelanotide is in Phase 3 development as a treatment for hypoactive sexual desire disorder in premenopausal women. The pivotal Phase 3 clinical trials were initiated in December 2014 and January 2015, respectively, with the efficacy portion completed back in August 2016. The topline data for the drug is expected to be available in the fourth quarter of 2016. If the data is positive, the data will support an NDA filing in 2H2017 and potential NDA approval in 2H2018.
For more information, visit www.Palatin.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Monaker Group, Inc. (MKGI) Announces Addition of Robert Post to Board of Directors
Technology-driven travel company Monaker Group, Inc. (OTCQB: MKGI) this morning announced the appointment of Robert Post, president and CEO of Cloud5 Communications and executive chairman of The Knowland Group, to its board of directors. Following this addition, the company’s board now includes six members, four of whom are serving independently.
“Bob’s appointment adds a tremendous wealth of senior-level experience, knowledge and accomplishments to our board,” Bill Kerby, chairman and CEO of Monaker Group, stated in this morning’s news release. “We expect Bob to provide valuable guidance and insights as the company enters a pivotal period in its growth and development. This includes our near-term launch of the industry’s first-ever ‘real-time’ alternative lodging reservation system, which also offers mainstream travel products and services all on a single site.”
All told, Post brings more than two decades of experience in the travel and hospitality sectors to the Monaker team. In addition to his time with Cloud5, the largest provider of cloud-based telecommunications and high speed internet services to some of the hospitality industry’s most recognizable brands, Post previously served as chairman and CEO of TravelCLICK, a leading provider of hotel e-commerce solutions with operations spanning 140 countries. Under his guidance, TravelCLICK grew from $35 million in annual revenue to more than $200 million, achieving high double-digit profitability. Post also served as the CFO and VP of business development of OpenTable.com, which was eventually acquired by the Priceline Group (NASDAQ: PCLN) for $2.6 billion.
For Monaker Group, the appointment of Robert Post as an independent addition to its board of directors is in line with previously announced intentions for a Nasdaq uplisting. Per Nasdaq listing requirements, the company will be required to maintain a majority of independent directors on its board in order to qualify for uplisting in the future.
Post’s appointment marks the second such announcement from Monaker Group during the first month of 2017. On January 5, the company announced the appointment of Simon Orange, the founding partner and chairman of CorpAcq, to its board. At the time of that appointment, CEO Bill Kerby noted that, while the addition of Orange to Monaker Group’s board of directors satisfied the listing requirements for an independent majority, the company planned to continue its “search and evaluation process to bring on additional board members” in an effort to strengthen its leadership and the composition of its board committees.
For more information, visit www.MonakerGroup.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
“Bob’s appointment adds a tremendous wealth of senior-level experience, knowledge and accomplishments to our board,” Bill Kerby, chairman and CEO of Monaker Group, stated in this morning’s news release. “We expect Bob to provide valuable guidance and insights as the company enters a pivotal period in its growth and development. This includes our near-term launch of the industry’s first-ever ‘real-time’ alternative lodging reservation system, which also offers mainstream travel products and services all on a single site.”
All told, Post brings more than two decades of experience in the travel and hospitality sectors to the Monaker team. In addition to his time with Cloud5, the largest provider of cloud-based telecommunications and high speed internet services to some of the hospitality industry’s most recognizable brands, Post previously served as chairman and CEO of TravelCLICK, a leading provider of hotel e-commerce solutions with operations spanning 140 countries. Under his guidance, TravelCLICK grew from $35 million in annual revenue to more than $200 million, achieving high double-digit profitability. Post also served as the CFO and VP of business development of OpenTable.com, which was eventually acquired by the Priceline Group (NASDAQ: PCLN) for $2.6 billion.
For Monaker Group, the appointment of Robert Post as an independent addition to its board of directors is in line with previously announced intentions for a Nasdaq uplisting. Per Nasdaq listing requirements, the company will be required to maintain a majority of independent directors on its board in order to qualify for uplisting in the future.
Post’s appointment marks the second such announcement from Monaker Group during the first month of 2017. On January 5, the company announced the appointment of Simon Orange, the founding partner and chairman of CorpAcq, to its board. At the time of that appointment, CEO Bill Kerby noted that, while the addition of Orange to Monaker Group’s board of directors satisfied the listing requirements for an independent majority, the company planned to continue its “search and evaluation process to bring on additional board members” in an effort to strengthen its leadership and the composition of its board committees.
For more information, visit www.MonakerGroup.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Wednesday, January 25, 2017
ITUS Corporation (NASDAQ: ITUS) is “One to Watch”
It is no secret that cancer remains a global epidemic. According to The National Cancer Institute (http://dtn.fm/RK8lF), cancer is still one of the leading causes of death in the world, with more than 8.2 million cancer-related deaths back in 2012. The American Cancer Society (http://dtn.fm/RK8lF) estimates that in 2017, just in the U.S., there will be over 1.6 million new cancer cases, with more than 600,000 cancer-related deaths, and the number of new cancer cases is expected to rise to 22 million within the next 20 years.
Some of the most common types of cancer expected in 2017 include breast cancer, lung and bronchus cancer, prostate cancer, colorectal cancer, melanoma of the skin, and urinary bladder cancer, with lung and bronchus cancer expected to be the biggest killers. Each of the types of cancer listed above needs to be detected early in order for patients to have the best survival rates, something made possible only with effective cancer screening tests.
ITUS Corporation (NASDAQ: ITUS), a company in the business of developing a series of non-invasive, inexpensive blood tests in order to detect cancer early on, has come up with Cchek™, a new form of cancer screening test that has proven to be more accurate, reliable, easy, and affordable than current screening tests. Cchek™ is a diagnostic platform that focuses on a subset of cells that are said to appear at the beginning of the formation of a tumor. By using proprietary protocols and fluorescently labeled antibodies, Cchek™ counts and sorts the specific and rare cells.
Currently, Cchek™ has been validated with 14 cancer types and has tested 315 patients, with 225 testing positive for cancer and 87 testing negative. In the preliminary results, the company achieved sensitivity and specificity of 92% accordingly for 88 patient samples, including 54 samples from patients with a variety of types of cancer, and 34 healthy patients. Sensitivity and specificity are two scientific measurements that are used to establish the efficacy of a diagnostic test.
ITUS Corporation is in the process of submitting its data at scientific meetings and plans to publish its data shortly. The company is continuing to process new patient samples with the aim of testing new cancer types while evaluating benign conditions. Currently, ITUS is still undertaking double-blinded testing in order to take Cchek™ to the U.S. Food and Drug Administration (FDA) for future approval.
For more information, visit www.ITUSCorp.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Some of the most common types of cancer expected in 2017 include breast cancer, lung and bronchus cancer, prostate cancer, colorectal cancer, melanoma of the skin, and urinary bladder cancer, with lung and bronchus cancer expected to be the biggest killers. Each of the types of cancer listed above needs to be detected early in order for patients to have the best survival rates, something made possible only with effective cancer screening tests.
ITUS Corporation (NASDAQ: ITUS), a company in the business of developing a series of non-invasive, inexpensive blood tests in order to detect cancer early on, has come up with Cchek™, a new form of cancer screening test that has proven to be more accurate, reliable, easy, and affordable than current screening tests. Cchek™ is a diagnostic platform that focuses on a subset of cells that are said to appear at the beginning of the formation of a tumor. By using proprietary protocols and fluorescently labeled antibodies, Cchek™ counts and sorts the specific and rare cells.
Currently, Cchek™ has been validated with 14 cancer types and has tested 315 patients, with 225 testing positive for cancer and 87 testing negative. In the preliminary results, the company achieved sensitivity and specificity of 92% accordingly for 88 patient samples, including 54 samples from patients with a variety of types of cancer, and 34 healthy patients. Sensitivity and specificity are two scientific measurements that are used to establish the efficacy of a diagnostic test.
ITUS Corporation is in the process of submitting its data at scientific meetings and plans to publish its data shortly. The company is continuing to process new patient samples with the aim of testing new cancer types while evaluating benign conditions. Currently, ITUS is still undertaking double-blinded testing in order to take Cchek™ to the U.S. Food and Drug Administration (FDA) for future approval.
For more information, visit www.ITUSCorp.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Monday, January 23, 2017
Monaker Group, Inc. (MKGI) Benefits When Business Travelers Add Leisure
Annual spending on leisure travel, at $650.8 billion in 2015, far exceeds spending on business travel, which totaled $296.3 billion during the same period, according to the U.S. Travel Association (http://dtn.fm/4Y0zB). But travelers are increasingly mixing business travel with leisure by extending their trips and combining the two. Monaker Group, Inc. (OTCQB: MKGI) serves this market through its subsidiaries, NextTrip.com, a real-time online booking platform, and Maupintour, which specializes in luxury and customized tours.
Monaker Group’s NextTrip.com and Maupintour offer technology-driven platforms which enable travelers to learn, plan, and execute their trips online. BridgeStreet Global Hospitality (http://dtn.fm/4B4iz) has found that travelers want sightseeing, dining and arts/culture in locations they were already traveling to for business.
According to the Global Business Travel Association (GBTA) (http://dtn.fm/rqAV7), 45% of employees at firms with less than 250 employees extended trips, compared to 38% at companies with 250-499 employees and just 30% at companies of 500 or more.
Some 52% are extending business trips with leisure travel with a spouse or significant other, the GBTA’s Business Travel Sentiment Index™ found in 2015. Further, 63% use the opportunity to explore the destination, and 48% said they would visit family or friends.
In the 2016 GBTA Index survey, mobile devices, social networks and apps were noted as important business travel tools. Some 72% of millennials and 64% of all business travelers check their travel itineraries at least once a day, and some 31% said they prefer to use electronic receipts instead of hard copies for tracking expenses.
Monaker Group has its own Monaker Booking Engine (MBE), which, in real time, has a global inventory of air, lodging, and tours, all viewable from a single online site. Travel bookings can be organized for the business traveler, the leisure traveler, or both. Monaker recently announced plans to release its own app for NextTrip on Android and iOS by the end of January 2017.
Additionally, Monaker Group has access to alternative lodging options for the traveler on its NextTrip.com site, with rentals of private residences or unused timeshare rooms in managed properties. In a news release, Bill Kerby, chairman and CEO of Monaker Group, said that the company is well positioned to take advantage of the trend to alternative lodging and travel. Monaker’s management team believes that the alternative lodging rental (ALR) market will reach $169 billion by 2019 and sees it as the fastest-growing segment of the business.
The company believes it is able to leverage its more than 60 years in leisure travel with new technology to best deliver its services. It said it plans to introduce artificial intelligence to NextTrip.com in the future under its ‘Travel Made Easy’ platform. Alternative travel includes everything from private residences available for rent to fractional shares of timeshare resort rooms.
Through NextTrip.com, Monaker Group is able to bring all of these elements in an online platform to the prospective traveler. Through Maupintour, it can organize even more specialized travel. Maupintour offers unique and luxury tours with a high repeat rate among travelers. Millennials want a single source for their combined business and leisure travel.
For more information, please visit www.MonakerGroup.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Monaker Group’s NextTrip.com and Maupintour offer technology-driven platforms which enable travelers to learn, plan, and execute their trips online. BridgeStreet Global Hospitality (http://dtn.fm/4B4iz) has found that travelers want sightseeing, dining and arts/culture in locations they were already traveling to for business.
According to the Global Business Travel Association (GBTA) (http://dtn.fm/rqAV7), 45% of employees at firms with less than 250 employees extended trips, compared to 38% at companies with 250-499 employees and just 30% at companies of 500 or more.
Some 52% are extending business trips with leisure travel with a spouse or significant other, the GBTA’s Business Travel Sentiment Index™ found in 2015. Further, 63% use the opportunity to explore the destination, and 48% said they would visit family or friends.
In the 2016 GBTA Index survey, mobile devices, social networks and apps were noted as important business travel tools. Some 72% of millennials and 64% of all business travelers check their travel itineraries at least once a day, and some 31% said they prefer to use electronic receipts instead of hard copies for tracking expenses.
Monaker Group has its own Monaker Booking Engine (MBE), which, in real time, has a global inventory of air, lodging, and tours, all viewable from a single online site. Travel bookings can be organized for the business traveler, the leisure traveler, or both. Monaker recently announced plans to release its own app for NextTrip on Android and iOS by the end of January 2017.
Additionally, Monaker Group has access to alternative lodging options for the traveler on its NextTrip.com site, with rentals of private residences or unused timeshare rooms in managed properties. In a news release, Bill Kerby, chairman and CEO of Monaker Group, said that the company is well positioned to take advantage of the trend to alternative lodging and travel. Monaker’s management team believes that the alternative lodging rental (ALR) market will reach $169 billion by 2019 and sees it as the fastest-growing segment of the business.
The company believes it is able to leverage its more than 60 years in leisure travel with new technology to best deliver its services. It said it plans to introduce artificial intelligence to NextTrip.com in the future under its ‘Travel Made Easy’ platform. Alternative travel includes everything from private residences available for rent to fractional shares of timeshare resort rooms.
Through NextTrip.com, Monaker Group is able to bring all of these elements in an online platform to the prospective traveler. Through Maupintour, it can organize even more specialized travel. Maupintour offers unique and luxury tours with a high repeat rate among travelers. Millennials want a single source for their combined business and leisure travel.
For more information, please visit www.MonakerGroup.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Westell Technologies, Inc. (NASDAQ: WSTL) Advancing Network Performance with Innovative Solutions
Since its inception back in 1980, Aurora, Illinois-based Westell Technologies, Inc. (NASDAQ: WSTL) has had one primary goal: that of ensuring top-quality communications to its customers. Almost four decades ago, this meant offering highly efficient transmission equipment and telephone signaling, but since then the company has expanded significantly and adapted to now offer some of the most technologically advanced, high-performance wireless infrastructure solutions in the telecom industry. Westell Technologies offers a comprehensive set of innovative products and service geared toward advancing network performance and helping network operators and service providers lower operating expenses. Serving primarily the U.S. market, Westell has expanded to also offer its products and services to Canada, South America, Africa, and Australia.
Westell’s innovative product solutions include Intelligent Site Management (ISM), Communication Network Solutions (CNS) and In-Building Wireless (IBW) via proprietary Clearlink® technology. The ISM solution helps users gain a competitive advantage when it comes to control and operation of their networks through remote visibility, a unitary control platform, lower operating costs, flexibility, adaptability, quality and maximum efficiency. Given the rapid expansion of wireless networks and the growing challenges this poses, the focus is now more on remote site management so as to lower maintenance costs and minimize troubleshooting. Westell provides comprehensive site management focused on communications management, power and security management and environmental management.
The company’s CNS include state-of-the-art network interfaces, power distribution systems, cabinets and enclosures, cell site optimization, system integration and also copper fiber management. The main goal of the company’s CNS is to help build reliable communications networks that can sustain harsh environmental conditions and still be able to connect any outdoor facility or building effectively, safely and efficiently.
Westell’s IBW segment is based on the company’s proprietary Clearlink® technology and includes various comprehensive solutions designed to ensure wireless coverage and capacity. IBW solutions include small cell deployments and distributed antenna systems, which are becoming increasingly common due to a significant spike in the use of mobile devices and data-intensive mobile services in office buildings, universities, airports and other public venues. The company’s Clearlink® IBW solution includes antennas, distributed antenna system radiofrequency conditioners, bi-directional amplifiers, digital repeaters and other types of system components aimed at improving overall network performance while lowering capital and operating costs.
In addition to its three main product groups, Westell also offers a comprehensive range of support and services to its customers so as to put together customized, complete solutions that best meet their business needs. Leveraging its 35+ years of experience in providing quality, innovative service to the industry, Westell makes available important technical knowledge and integration services, as well as training classes and general support designed to help all of its customers, from service providers to tower operators and other network operators.
For more information, visit www.Westell.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Westell’s innovative product solutions include Intelligent Site Management (ISM), Communication Network Solutions (CNS) and In-Building Wireless (IBW) via proprietary Clearlink® technology. The ISM solution helps users gain a competitive advantage when it comes to control and operation of their networks through remote visibility, a unitary control platform, lower operating costs, flexibility, adaptability, quality and maximum efficiency. Given the rapid expansion of wireless networks and the growing challenges this poses, the focus is now more on remote site management so as to lower maintenance costs and minimize troubleshooting. Westell provides comprehensive site management focused on communications management, power and security management and environmental management.
The company’s CNS include state-of-the-art network interfaces, power distribution systems, cabinets and enclosures, cell site optimization, system integration and also copper fiber management. The main goal of the company’s CNS is to help build reliable communications networks that can sustain harsh environmental conditions and still be able to connect any outdoor facility or building effectively, safely and efficiently.
Westell’s IBW segment is based on the company’s proprietary Clearlink® technology and includes various comprehensive solutions designed to ensure wireless coverage and capacity. IBW solutions include small cell deployments and distributed antenna systems, which are becoming increasingly common due to a significant spike in the use of mobile devices and data-intensive mobile services in office buildings, universities, airports and other public venues. The company’s Clearlink® IBW solution includes antennas, distributed antenna system radiofrequency conditioners, bi-directional amplifiers, digital repeaters and other types of system components aimed at improving overall network performance while lowering capital and operating costs.
In addition to its three main product groups, Westell also offers a comprehensive range of support and services to its customers so as to put together customized, complete solutions that best meet their business needs. Leveraging its 35+ years of experience in providing quality, innovative service to the industry, Westell makes available important technical knowledge and integration services, as well as training classes and general support designed to help all of its customers, from service providers to tower operators and other network operators.
For more information, visit www.Westell.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Function(x) Inc. (NASDAQ: FNCX) Stole a March on the Women’s March with Wetpaint for Millennial Women
The hundreds of thousands of women who attended the Women’s March on Washington and its ‘sister’ marches across the nation and around the world attest to the magnitude of ‘girl power’. The status of women has certainly changed from what it was in the 15th century, when the English clergyman, John Mirk, wrote in a homily that survives, slightly altered, to this day: a maid should be seen, but not heard.
The multitude of maids that paraded across Independence Avenue and at other locations was certainly seen and definitely heard. The modern woman takes an active role in public affairs, but she also indulges her fancy for lighter fare by visiting the Function(x) Inc. (NASDAQ: FNCX) website Wetpaint, which, for over six years now, has been serving millennial women with the latest entertainment scoops, including television, music, and pop culture news.
Millennials, or those born between 1982 and 2000, make up about one-quarter of the U.S. population. At 83.1 million, they now outnumber the 75.4 million Baby Boomers, according to recent Census Bureau (http://dtn.fm/BlAo7) data. Their numbers mean they cannot be ignored.
A feature on NewsCred Insights (http://dtn.fm/pNS12) stressed the need for those who market to Millennials to have relevant content. It also pointed out that you can ‘catch Millennials where they live: on social media’. Millennial women, it seems, make up the majority of users on social media platforms such as Facebook, Pinterest and Instagram. Men prefer online discussion forums like the once profanity-laced Reddit. Gender differences on Twitter, Tumblr and LinkedIn are not, according to the Pew Research Center (http://dtn.fm/yX1BZ), significant. Most fascinating of all was the discovery that 70 percent of millennial women consider shopping to be entertainment. Who would have guessed?
That’s why, in 2010, Function(x) launched the Wetpaint Entertainment platform designed to offer the 18–34 year old female demographic information, entertainment and information on entertainment. On Wetpaint, Generation Y females can get the latest updates and breaking news on TV shows, celebrities, reality gossip, music, and fashion. The site, which depends on an advertising-based revenue model, publishes more than 55 new articles, videos and galleries each day.
To enhance its digital publishing business, Function(x) recently acquired the assets of Rant Inc., a leading digital publisher of original content across 13 different verticals, most notably in sports, entertainment, pets, cars, and food. The combined Wetpaint and Rant properties currently have approximately 13.5 million fans on their Facebook pages and generate an average of 14.4 million visits per month.
Another Function(x) property is Choose Digital, a white-label digital marketplace featuring a wide up-to-date range of digital content, including music, movies, TV shows, e-Books and audio books. The site offers an aggregation of movie and TV content plus content sourced from the world’s leading record companies and book publishers.
Function(x) also offers a daily fantasy sports experience both directly to consumers and to businesses desiring turnkey solutions through its majority ownership of DraftDay Gaming Group, which is well-positioned to become a significant player in the explosive fantasy sports market.
For more information, visit www.FunctionxInc.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
The multitude of maids that paraded across Independence Avenue and at other locations was certainly seen and definitely heard. The modern woman takes an active role in public affairs, but she also indulges her fancy for lighter fare by visiting the Function(x) Inc. (NASDAQ: FNCX) website Wetpaint, which, for over six years now, has been serving millennial women with the latest entertainment scoops, including television, music, and pop culture news.
Millennials, or those born between 1982 and 2000, make up about one-quarter of the U.S. population. At 83.1 million, they now outnumber the 75.4 million Baby Boomers, according to recent Census Bureau (http://dtn.fm/BlAo7) data. Their numbers mean they cannot be ignored.
A feature on NewsCred Insights (http://dtn.fm/pNS12) stressed the need for those who market to Millennials to have relevant content. It also pointed out that you can ‘catch Millennials where they live: on social media’. Millennial women, it seems, make up the majority of users on social media platforms such as Facebook, Pinterest and Instagram. Men prefer online discussion forums like the once profanity-laced Reddit. Gender differences on Twitter, Tumblr and LinkedIn are not, according to the Pew Research Center (http://dtn.fm/yX1BZ), significant. Most fascinating of all was the discovery that 70 percent of millennial women consider shopping to be entertainment. Who would have guessed?
That’s why, in 2010, Function(x) launched the Wetpaint Entertainment platform designed to offer the 18–34 year old female demographic information, entertainment and information on entertainment. On Wetpaint, Generation Y females can get the latest updates and breaking news on TV shows, celebrities, reality gossip, music, and fashion. The site, which depends on an advertising-based revenue model, publishes more than 55 new articles, videos and galleries each day.
To enhance its digital publishing business, Function(x) recently acquired the assets of Rant Inc., a leading digital publisher of original content across 13 different verticals, most notably in sports, entertainment, pets, cars, and food. The combined Wetpaint and Rant properties currently have approximately 13.5 million fans on their Facebook pages and generate an average of 14.4 million visits per month.
Another Function(x) property is Choose Digital, a white-label digital marketplace featuring a wide up-to-date range of digital content, including music, movies, TV shows, e-Books and audio books. The site offers an aggregation of movie and TV content plus content sourced from the world’s leading record companies and book publishers.
Function(x) also offers a daily fantasy sports experience both directly to consumers and to businesses desiring turnkey solutions through its majority ownership of DraftDay Gaming Group, which is well-positioned to become a significant player in the explosive fantasy sports market.
For more information, visit www.FunctionxInc.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Friday, January 20, 2017
Catalyst Pharmaceuticals (NASDAQ: CPRX) Offering Novel Therapies for Rare Diseases
A Florida-based biopharmaceutical company is giving hope to patients with rare debilitating diseases by developing innovative therapies designed specifically to improve and alleviate their symptoms. The main focus of Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is the development of a treatment for Lambert-Eaton Myasthenic Syndrome (LEMS) – a rare, autoimmune, neuromuscular disorder characterized by muscle weakness and autonomic dysfunction.
With a prevalence of approximately 1 in 100,000 people in the United States and Canada, this ailment can be severely debilitating, as its primary symptoms are severe muscle weakness and fatigue. The disease occurs when the immune system starts attacking the nerves that control muscles, more specifically nerve cell proteins that regulate how much acetylcholine, a neurotransmitter, is released. When the body cannot release enough of it, regular muscle contractions that allow walking, wiggling one’s fingers or shrugging one’s shoulders become almost impossible. In addition to these symptoms, approximately 50 percent of LEMS patients also develop a form of cancer, typically small cell lung cancer.
Catalyst Pharmaceuticals is currently developing amifampridine phosphate specifically for the treatment of LEMS and possibly other neuromuscular disorders. The company has recently completed a crucial Phase 3 clinical trial for amifampridine phosphate with positive top-line results: the 38 subject, global, multi-center study showed that the product is safe and effective in the treatment of LEMS Patients. The therapy has already received the Orphan Drug and Breakthrough Therapy designations from the Food and Drug Administration, which means that it can be made available on a compassionate use basis to patients who really need it, pending FDA’s approval for commercialization. Clinical trial participants can get continued access to the treatment through the Amifampridine Phosphate Expanded Access Program recently initiated by Catalyst Pharmaceuticals. In the meantime, the company continues its work to secure FDA approval for the therapy so as to begin commercializing it under the proposed tradename of Firdapse®.
The company believes this product has the potential to treat several other neuromuscular disorders including Congenital Myasthenic Syndromes (CMS) and some cases of myasthenia gravis that do not respond to regular approved therapies. These possible applications of the treatment are also mentioned in the NDA that Catalyst recently filed with the Food and Drug Administration. CMS is a rare autoimmune disorder that starts affecting patients shortly after birth or in their early childhood. Ranging in severity from minor to disabling symptoms, its main effect is a significant fatigable weakness of skeletal muscles that can even lead to episodes of respiratory insufficiency if other conditions, such as fever or infections, are present. Another condition that could be improved by amifampridine phosphate is downbeat nystagmus, popularly known as “dancing eyes” because of its most common symptom: involuntary rhythmic oscillations of the eyes.
In addition to amifampridine phosphate, Catalyst Pharmaceuticals is also developing CPP-115, a very potent GABA-aminotransferase inhibitor for the treatment of infantile spasms or seizures. In-vitro studies have indicated that CPP-115 is 200 times stronger than traditional therapies for this condition and that it may also have fewer side effects. Besides infantile spasms, CPP-115 might prove effective against a wide range of conditions, including other forms of epilepsy or central nervous system ailments such as Tourette Syndrome and PTSD.
For more information, visit www.CatalystPharma.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
With a prevalence of approximately 1 in 100,000 people in the United States and Canada, this ailment can be severely debilitating, as its primary symptoms are severe muscle weakness and fatigue. The disease occurs when the immune system starts attacking the nerves that control muscles, more specifically nerve cell proteins that regulate how much acetylcholine, a neurotransmitter, is released. When the body cannot release enough of it, regular muscle contractions that allow walking, wiggling one’s fingers or shrugging one’s shoulders become almost impossible. In addition to these symptoms, approximately 50 percent of LEMS patients also develop a form of cancer, typically small cell lung cancer.
Catalyst Pharmaceuticals is currently developing amifampridine phosphate specifically for the treatment of LEMS and possibly other neuromuscular disorders. The company has recently completed a crucial Phase 3 clinical trial for amifampridine phosphate with positive top-line results: the 38 subject, global, multi-center study showed that the product is safe and effective in the treatment of LEMS Patients. The therapy has already received the Orphan Drug and Breakthrough Therapy designations from the Food and Drug Administration, which means that it can be made available on a compassionate use basis to patients who really need it, pending FDA’s approval for commercialization. Clinical trial participants can get continued access to the treatment through the Amifampridine Phosphate Expanded Access Program recently initiated by Catalyst Pharmaceuticals. In the meantime, the company continues its work to secure FDA approval for the therapy so as to begin commercializing it under the proposed tradename of Firdapse®.
The company believes this product has the potential to treat several other neuromuscular disorders including Congenital Myasthenic Syndromes (CMS) and some cases of myasthenia gravis that do not respond to regular approved therapies. These possible applications of the treatment are also mentioned in the NDA that Catalyst recently filed with the Food and Drug Administration. CMS is a rare autoimmune disorder that starts affecting patients shortly after birth or in their early childhood. Ranging in severity from minor to disabling symptoms, its main effect is a significant fatigable weakness of skeletal muscles that can even lead to episodes of respiratory insufficiency if other conditions, such as fever or infections, are present. Another condition that could be improved by amifampridine phosphate is downbeat nystagmus, popularly known as “dancing eyes” because of its most common symptom: involuntary rhythmic oscillations of the eyes.
In addition to amifampridine phosphate, Catalyst Pharmaceuticals is also developing CPP-115, a very potent GABA-aminotransferase inhibitor for the treatment of infantile spasms or seizures. In-vitro studies have indicated that CPP-115 is 200 times stronger than traditional therapies for this condition and that it may also have fewer side effects. Besides infantile spasms, CPP-115 might prove effective against a wide range of conditions, including other forms of epilepsy or central nervous system ailments such as Tourette Syndrome and PTSD.
For more information, visit www.CatalystPharma.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Thursday, January 19, 2017
eXp World Holdings, Inc. (EXPI) Operating in a Way that Contributes to Improvements in Environmental Sustainability
Despite many real estate firms having environmental policies, sustainability targets, and clear commitments and strategies to lower their carbon emissions, the real estate sector still uses more energy than any other sector. This is according to the ‘Environmental sustainability Principles for the Real Estate Industry’ report published by World Economic Forum (http://dtn.fm/Rb5J2), which views real estate as the operational life of the final buildings and not just what’s involved in their initial construction. In other words, how “green” are our buildings?
According to the report, not only are buildings the source of the most energy consumption, they are, understandably, also a growing contributor to CO2 emissions. In fact, real estate consumes over 40% of global energy every year. In addition, 20% of greenhouse gas emissions originate from buildings, a number that’s expected to increase 56% by the year 2030. The report continues to explain that, by 2030, buildings are expected to use up to 12% of the world’s fresh water.
However, although a large proportion of the world’s real estate already existed before eco-friendly policies were put in place, progress is being made toward “greener” real estate. The number of “green” commercial builds increased to between 40% and 48% in 2016, up from only 2% in 2005. Additionally, regulations are now in place to ensure that businesses work toward sustainability performance.
In support of these efforts, companies such as eXp World Holdings, Inc. (OTCQB: EXPI) are completely changing the way the real estate industry itself functions. Gone are the days during which agents and brokers were expected to work in a brick and mortar office. EXPI has not only cut unnecessary expenses and built an agent-owned, cloud-based real estate brokerage that operates without the need for offices, utility bills, insurance, furnishings, and redundant staffing costs, the company has correspondingly cut its direct CO2 emissions.
Aside from the financial benefits of operating in the cloud, EXPI provides an extremely sound template for a more sustainable way of operating a real estate brokerage on all levels. The company works on the basis that its most valuable asset is the group of agents and brokers who are part of it. And, with no physical constrictions, eXp World Holdings, Inc. can focus its efforts on these assets while providing smart solutions to the climate concerns that the world is now facing, further championing sustainability across the entire real estate industry.
For more information, visit the company’s website at www.eXpWorldHoldings.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
According to the report, not only are buildings the source of the most energy consumption, they are, understandably, also a growing contributor to CO2 emissions. In fact, real estate consumes over 40% of global energy every year. In addition, 20% of greenhouse gas emissions originate from buildings, a number that’s expected to increase 56% by the year 2030. The report continues to explain that, by 2030, buildings are expected to use up to 12% of the world’s fresh water.
However, although a large proportion of the world’s real estate already existed before eco-friendly policies were put in place, progress is being made toward “greener” real estate. The number of “green” commercial builds increased to between 40% and 48% in 2016, up from only 2% in 2005. Additionally, regulations are now in place to ensure that businesses work toward sustainability performance.
In support of these efforts, companies such as eXp World Holdings, Inc. (OTCQB: EXPI) are completely changing the way the real estate industry itself functions. Gone are the days during which agents and brokers were expected to work in a brick and mortar office. EXPI has not only cut unnecessary expenses and built an agent-owned, cloud-based real estate brokerage that operates without the need for offices, utility bills, insurance, furnishings, and redundant staffing costs, the company has correspondingly cut its direct CO2 emissions.
Aside from the financial benefits of operating in the cloud, EXPI provides an extremely sound template for a more sustainable way of operating a real estate brokerage on all levels. The company works on the basis that its most valuable asset is the group of agents and brokers who are part of it. And, with no physical constrictions, eXp World Holdings, Inc. can focus its efforts on these assets while providing smart solutions to the climate concerns that the world is now facing, further championing sustainability across the entire real estate industry.
For more information, visit the company’s website at www.eXpWorldHoldings.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
National Waste Management Holdings, Inc. (NWMH) Committed to Reducing C&D Waste Environmental Impact
Construction and demolition (C&D) debris occupies a significant portion of the entire waste stream in the United States, and improper disposal or failure to reuse or recycle this type of waste can have a major impact on the environment. According to the U.S. Environmental Protection Agency (http://dtn.fm/7kyMX), C&D waste amounted to more than 530 million tons in 2014, which was twice as much as the amount of solid municipal waste generated nationwide. Most of this debris (over 90 percent) came from demolition works, while the rest came from construction projects. The largest sector that generated C&D waste was non-residential demolition, followed by residential renovation, the EPA figures show.
Typically consisting of bulky, heavy materials such as wood products, steel, drywall, plaster, bricks and clay tiles, concrete and asphalt and even building components, C&D waste is more difficult to handle, so proper disposal and/or recycling often requires an extra effort on behalf of the contractor or beneficiary of the construction project. Most C&D debris ends up in a landfill, and that is considered the end of its lifecycle. However, due to the EPA’s Sustainable Materials Management approach, a growing volume of construction and demolition waste is now being recovered and recycled, thus reducing the need to mine for virgin materials.
Florida-based National Waste Management Holdings, Inc. (OTC: NWMH), a professional waste management operator offering a comprehensive suite of relevant services, is committed to recycling as much C&D waste as possible from all of its services, primarily from its 54-acre landfill located in Hernando, Florida. The landfill is authorized by the Florida Department of Environmental Protection and disposes of roughly 240,000 cubic yards of C&D waste every year.
With a strong dedication to Department of Environmental Protection standards and to the Sustainable Materials Management approach, National Waste Management Holdings focuses on reducing the volume of excessive waste by recycling several C&D materials. For this purpose, it has transformed its entire line of services to focus on recycling and has plans to set up a portable waste sorting line at its landfill this year, so as to increase recyclable rates. The company receives a wide range of approved C&D waste at its landfill, including asphalt; brick; drywall and plaster; lumber and wood; pallets; dirt, sand and uncontaminated soil; roofing materials; glass; metal materials; non-asbestos insulation; electrical wiring and components; and more.
In its efforts to further reduce the environmental impact of C&D debris, National Waste Management Holdings has already found a great use for the wood debris collected through its landfill and transfer stations: it manufactures and sells its own line of proprietary mulch, a high-quality product already used to help beautify homes and commercial properties throughout west and central Florida. The mulch is made entirely of recycled wood and is available either in natural color or red dyed.
According to the EPA, reducing the amount of C&D debris disposed of in landfills can have significant economic and environmental benefits, such as preserving landfill space; having fewer disposal facilities, which can lower methane gas emissions and other associated environmental issues; reducing the negative environmental impact associated with the extraction and production of virgin construction materials; adding new economic and employment opportunities in the recycling industry; and creating additional business opportunities for local communities.
For more information, visit the company’s website at www.nationalwastemgmt.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Typically consisting of bulky, heavy materials such as wood products, steel, drywall, plaster, bricks and clay tiles, concrete and asphalt and even building components, C&D waste is more difficult to handle, so proper disposal and/or recycling often requires an extra effort on behalf of the contractor or beneficiary of the construction project. Most C&D debris ends up in a landfill, and that is considered the end of its lifecycle. However, due to the EPA’s Sustainable Materials Management approach, a growing volume of construction and demolition waste is now being recovered and recycled, thus reducing the need to mine for virgin materials.
Florida-based National Waste Management Holdings, Inc. (OTC: NWMH), a professional waste management operator offering a comprehensive suite of relevant services, is committed to recycling as much C&D waste as possible from all of its services, primarily from its 54-acre landfill located in Hernando, Florida. The landfill is authorized by the Florida Department of Environmental Protection and disposes of roughly 240,000 cubic yards of C&D waste every year.
With a strong dedication to Department of Environmental Protection standards and to the Sustainable Materials Management approach, National Waste Management Holdings focuses on reducing the volume of excessive waste by recycling several C&D materials. For this purpose, it has transformed its entire line of services to focus on recycling and has plans to set up a portable waste sorting line at its landfill this year, so as to increase recyclable rates. The company receives a wide range of approved C&D waste at its landfill, including asphalt; brick; drywall and plaster; lumber and wood; pallets; dirt, sand and uncontaminated soil; roofing materials; glass; metal materials; non-asbestos insulation; electrical wiring and components; and more.
In its efforts to further reduce the environmental impact of C&D debris, National Waste Management Holdings has already found a great use for the wood debris collected through its landfill and transfer stations: it manufactures and sells its own line of proprietary mulch, a high-quality product already used to help beautify homes and commercial properties throughout west and central Florida. The mulch is made entirely of recycled wood and is available either in natural color or red dyed.
According to the EPA, reducing the amount of C&D debris disposed of in landfills can have significant economic and environmental benefits, such as preserving landfill space; having fewer disposal facilities, which can lower methane gas emissions and other associated environmental issues; reducing the negative environmental impact associated with the extraction and production of virgin construction materials; adding new economic and employment opportunities in the recycling industry; and creating additional business opportunities for local communities.
For more information, visit the company’s website at www.nationalwastemgmt.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Wednesday, January 18, 2017
Ballard Power (NASDAQ: BLDP) Buys 100% of Its European Subsidiary, Grows Globally
Ballard Power Systems (NASDAQ: BLDP) (TSX: BLDP) has purchased complete ownership of its European subsidiary from Dansk Industri Invest A/S for what it termed a “nominal value”. The subsidiary is now named Ballard Power Systems Europe A/S.
With that name change, the subsidiary will now use the Ballard brand, such as visual identity and logo, and will play an expanded role in supporting all of Ballard’s activities in Europe. The transaction will enable the company to not only acquire all the shares of the company, but also cancel the debt owed by the parent company to Dansk Industri. Prior to this, Ballard held 57% of the shares of the subsidiary, while Dansk Industri held the other 43%.
Ballard is a clean power company that specializes in fuel cell stack development (proton exchange membrane), fuel processing and systems integration. Ballard is considered one of the key vendors in the global fuel cell market. The company has announced that its fuel cells, branded as FCveloCity®, are in engines used in 80 buses internationally in Europe, China, the United States, Brazil, and India. Ballard is currently focused on expanding within the countries in which it is already operating, as well as adding to the list of countries using its fuel cell engines. Other transportation systems also use the technology, such as light rail.
The acquisition of the subsidiary closed on January 5, 2017. In a news release, Tony Guglielmin, CFO of Ballard Power Systems and chairman of Ballard Power Systems Europe A/S, said the company began the takeover process two years ago. “Europe is a critically important market for Ballard and we have taken important steps to strengthen our sales, engineering and service capabilities to support expected market growth,” he noted. About 50 employees work at the European subsidiary based in Hobro, Denmark. Ballard’s headquarters are located in Burnaby, British Columbia, in Canada.
Randy MacEwen, Ballard president and CEO, also said that the company achieved 10 million cumulative kilometers (6.2 million miles) worldwide with vehicles powered by its fuel cell motors. “We are moving beyond technical validation into commercial scaling at a time where market demand is at a breakthrough inflection point,” he said. “The cumulative learning by Ballard during our unparalleled field experience serves as a major competitive differentiator.” The company said it is seeing increased market demand for its fuel cell engines.
Ballard Power recently reported its third quarter results, with revenues for the three-month period ended September 30, 2016, totaling $20.6 million, compared to $16.0 million for the same period of the prior year. For the nine months ended September 30, 2016, revenues were $54.6 million, versus $36.5 million the prior year. Shares of Ballard were trading at $1.91 on the Nasdaq Global Market as of January 17, 2017.
Last month, Ballard announced that its stock ticker symbol on the Toronto Stock Exchange (TSX) had been changed to BLDP. The result is that the company now has the same ticker symbol on both the Nasdaq and TSX.
Ballard was named one of the nation’s Top 20 innovative public technology companies by the Canadian Innovation Exchange (CIX).
For more information, please visit www.Ballard.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
With that name change, the subsidiary will now use the Ballard brand, such as visual identity and logo, and will play an expanded role in supporting all of Ballard’s activities in Europe. The transaction will enable the company to not only acquire all the shares of the company, but also cancel the debt owed by the parent company to Dansk Industri. Prior to this, Ballard held 57% of the shares of the subsidiary, while Dansk Industri held the other 43%.
Ballard is a clean power company that specializes in fuel cell stack development (proton exchange membrane), fuel processing and systems integration. Ballard is considered one of the key vendors in the global fuel cell market. The company has announced that its fuel cells, branded as FCveloCity®, are in engines used in 80 buses internationally in Europe, China, the United States, Brazil, and India. Ballard is currently focused on expanding within the countries in which it is already operating, as well as adding to the list of countries using its fuel cell engines. Other transportation systems also use the technology, such as light rail.
The acquisition of the subsidiary closed on January 5, 2017. In a news release, Tony Guglielmin, CFO of Ballard Power Systems and chairman of Ballard Power Systems Europe A/S, said the company began the takeover process two years ago. “Europe is a critically important market for Ballard and we have taken important steps to strengthen our sales, engineering and service capabilities to support expected market growth,” he noted. About 50 employees work at the European subsidiary based in Hobro, Denmark. Ballard’s headquarters are located in Burnaby, British Columbia, in Canada.
Randy MacEwen, Ballard president and CEO, also said that the company achieved 10 million cumulative kilometers (6.2 million miles) worldwide with vehicles powered by its fuel cell motors. “We are moving beyond technical validation into commercial scaling at a time where market demand is at a breakthrough inflection point,” he said. “The cumulative learning by Ballard during our unparalleled field experience serves as a major competitive differentiator.” The company said it is seeing increased market demand for its fuel cell engines.
Ballard Power recently reported its third quarter results, with revenues for the three-month period ended September 30, 2016, totaling $20.6 million, compared to $16.0 million for the same period of the prior year. For the nine months ended September 30, 2016, revenues were $54.6 million, versus $36.5 million the prior year. Shares of Ballard were trading at $1.91 on the Nasdaq Global Market as of January 17, 2017.
Last month, Ballard announced that its stock ticker symbol on the Toronto Stock Exchange (TSX) had been changed to BLDP. The result is that the company now has the same ticker symbol on both the Nasdaq and TSX.
Ballard was named one of the nation’s Top 20 innovative public technology companies by the Canadian Innovation Exchange (CIX).
For more information, please visit www.Ballard.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Tuesday, January 17, 2017
Monaker Group, Inc. (MKGI) Makes Business-Leisure Travel More Accessible
At one time there was a feeling that, in an age where virtually everything is connected and platforms such as Skype and Facetime make video conferencing easily accessible, traveling for business would no longer be necessary. However, according to Globetouch (http://dtn.fm/rsN9l), the Asia-Pacific region doubled its business travel output between 2005 and 2015, with these numbers expected to grow further during the coming years.
This has been attributed, in part, to the fact that more people are learning how to combine business travel with leisure, encouraging many to look upon business travel as a positive. According to ‘Predictions: The 8 Hot Travel Trends In 2017’ (http://dtn.fm/6Igkt), a WIT article, “30% of travelers said they would accept a lower paid job if it meant they could travel more for work.” It also states that “Of the 40% of global travelers who journeyed for business this year, 46% would travel even more for business in 2017.”
Businessmen and women are realizing that it is possible to combine work and pleasure, and opting to travel more for work makes the leisure opportunities more affordable. With many business travelers today being millennials, they expect a seamless travel experience, where they can see to their business affairs while incorporating some rest and relaxation into their trips. With the help of technology, this has been made possible.
Monaker Group, Inc. (OTCQB: MKGI), a technology driven travel company with a number of divisions and brands boasting more than 60 years of combined experience in the travel and leisure industry, provides an all-in-one platform through its flagship NextTrip.com planner, which makes planning work and leisure combination travel easy.
The NextTrip.com travel planner works with a range of mobile devices, and it allows those traveling for both business and pleasure to organize and plan a trip from start to finish. Including rental homes, hotels, timeshare resorts, airlines, tours, and car rentals, the travel planner makes the multitude of options clear to the user on one screen. In addition to the above, the planner gives users the chance to import all bookings onto one device; find attractions, restaurants, and bars in their desired locations; and maintain a level of financial organization, all for free.
For more information, visit www.MonakerGroup.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
This has been attributed, in part, to the fact that more people are learning how to combine business travel with leisure, encouraging many to look upon business travel as a positive. According to ‘Predictions: The 8 Hot Travel Trends In 2017’ (http://dtn.fm/6Igkt), a WIT article, “30% of travelers said they would accept a lower paid job if it meant they could travel more for work.” It also states that “Of the 40% of global travelers who journeyed for business this year, 46% would travel even more for business in 2017.”
Businessmen and women are realizing that it is possible to combine work and pleasure, and opting to travel more for work makes the leisure opportunities more affordable. With many business travelers today being millennials, they expect a seamless travel experience, where they can see to their business affairs while incorporating some rest and relaxation into their trips. With the help of technology, this has been made possible.
Monaker Group, Inc. (OTCQB: MKGI), a technology driven travel company with a number of divisions and brands boasting more than 60 years of combined experience in the travel and leisure industry, provides an all-in-one platform through its flagship NextTrip.com planner, which makes planning work and leisure combination travel easy.
The NextTrip.com travel planner works with a range of mobile devices, and it allows those traveling for both business and pleasure to organize and plan a trip from start to finish. Including rental homes, hotels, timeshare resorts, airlines, tours, and car rentals, the travel planner makes the multitude of options clear to the user on one screen. In addition to the above, the planner gives users the chance to import all bookings onto one device; find attractions, restaurants, and bars in their desired locations; and maintain a level of financial organization, all for free.
For more information, visit www.MonakerGroup.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
An Update on Axsome Therapeutics, Inc. (NASDAQ: AXSM)
Once New York-based Axsome Therapeutics, Inc. (NASDAQ: AXSM) was founded in 2012, its team set out to establish a fully-integrated biopharmaceutical business that would develop therapies to treat and manage central nervous system (CNS) disorders. Now in 2017, the Axsome team is setting off on another exciting leg on this journey.
For years, Axsome has been laser-focused on improving the lives of patients living with pain and various CNS disorders. With an eye toward differentiated therapies, the company has concentrated on developing and commercializing both in-licensed drug candidates and internally-derived drug candidates in order to accomplish its goal of increasing the treatment options accessible to caregivers.
Along the way, industry analysts have pointed out the value in Axsome’s focus on complex regional pain syndrome, treatment resistant depression and agitation in patients with Alzheimer’s disease (AD); the lower-than-average research and development risks, as well as the tested business models that surround these disorders, hint at a faster commercialization schedule.
During the first week of 2017, a new report from AEGIS Capital Corp. (http://dtn.fm/w6MIe) also alluded to Axsome’s accelerated timeline and other investment highlights, including recent developments affecting one of the company’s two late-stage drug candidates: AXS-05, a fixed-dose combination of dextromethorphan and bupropion that is being developed for multiple indications, including treatment resistant depression and agitation in patients with AD.
According to the AEGIS report, on January 4, 2017, Axsome announced that the United States’ Food and Drug Administration (FDA) had cleared its Investigational New Drug (IND) application for a phase II/III clinical trial of AXS-05 in AD. This is a significant development for the company, as this IND program is the means by which a pharmaceutical company operating within the United States obtains permission to ship an experimental drug across state lines (usually to clinical investigators) before a marketing application for the drug has been approved. With the FDA’s approval in tow, the placebo-controlled, randomized, double-blind, multicenter trial is now set to register the necessary 330 patients and to commence sometime in the first half of 2017.
To learn more, visit www.Axsome.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
For years, Axsome has been laser-focused on improving the lives of patients living with pain and various CNS disorders. With an eye toward differentiated therapies, the company has concentrated on developing and commercializing both in-licensed drug candidates and internally-derived drug candidates in order to accomplish its goal of increasing the treatment options accessible to caregivers.
Along the way, industry analysts have pointed out the value in Axsome’s focus on complex regional pain syndrome, treatment resistant depression and agitation in patients with Alzheimer’s disease (AD); the lower-than-average research and development risks, as well as the tested business models that surround these disorders, hint at a faster commercialization schedule.
During the first week of 2017, a new report from AEGIS Capital Corp. (http://dtn.fm/w6MIe) also alluded to Axsome’s accelerated timeline and other investment highlights, including recent developments affecting one of the company’s two late-stage drug candidates: AXS-05, a fixed-dose combination of dextromethorphan and bupropion that is being developed for multiple indications, including treatment resistant depression and agitation in patients with AD.
According to the AEGIS report, on January 4, 2017, Axsome announced that the United States’ Food and Drug Administration (FDA) had cleared its Investigational New Drug (IND) application for a phase II/III clinical trial of AXS-05 in AD. This is a significant development for the company, as this IND program is the means by which a pharmaceutical company operating within the United States obtains permission to ship an experimental drug across state lines (usually to clinical investigators) before a marketing application for the drug has been approved. With the FDA’s approval in tow, the placebo-controlled, randomized, double-blind, multicenter trial is now set to register the necessary 330 patients and to commence sometime in the first half of 2017.
To learn more, visit www.Axsome.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
National Waste Management Holdings, Inc. (NWMH) Turns Trash into Treasure, Records Strong Revenue Growth
National Waste Management Holdings, Inc. (OTC: NWMH) has turned the old aphorism ‘garbage in – garbage out’ on its head. It’s now ‘garbage in, revenues up’. In its last 10-Q filing, for the third quarter ended September 30, 2016, the company reported quarterly revenues of $1.8 million, which represented a 269 percent increase over 2015 same period revenues. This stellar performance in the third quarter boosted revenues in the nine-month period ended September 30, 2016, to $4.9 million, up by 262 percent over same period revenues for 2015. Not all garbage, it seems, is waste.
National Waste operates a licensed 54-acre landfill in Hernando, Florida, that disposes of roughly 240,000 cubic yards of construction debris annually. These landfill services include the disposal of asphalt and rock; lumber and wood; brick; wallboard, drywall and plaster; pallets; rock concrete; dirt, sand and uncontaminated soil; plumbing fixtures; non-asbestos insulation; roofing materials and shingles; glass; piping; waste metal; brush and land clearing; yard and tree waste; and many electrical and wiring components.
However, as extensive as those facilities are, they do not encompass the whole range of landfill services. There’s a lot more to garbage disposal than meets the eye.
Solid waste, defined as household garbage and industrial non-hazardous waste, is disposed of in a variety of landfills. Municipal solid waste landfills (MSWLF) are designed to accommodate the disposal of household waste but may accept other types of non-hazardous wastes, such as commercial solid waste, non-hazardous sludge, and industrial non-hazardous solid waste. A special kind of MSWLF is the bioreactor landfill, designed to degrade waste in a controlled manner.
Even though some commercial solid waste and industrial non-hazardous solid waste ends up in MSWLFs, there are special facilities, known as industrial waste landfills, designed to take commercial and institutional waste. In this category are construction and demolition (C&D) debris landfills, designed exclusively for construction and demolition materials, which consist of the debris generated during the construction, renovation and demolition of buildings, roads and bridges. C&D materials are typically bulky, heavy materials, such as concrete, wood, metals, glass and salvaged building components.
Another type of industrial waste landfill is the coal combustion residual (CCR) landfill, which is meant to accommodate coal ash and other residuals from coal combustion.
With such a heterogeneous landscape, there is ample opportunity for National Waste to continue the implementation of its vertical integration strategy. Apart from its landfill services, the company rents out roll-off containers of 20, 30 and 40 cubic yard capacity. It also offers recycled wood mulch and garden mulch products. The route is clear for National Waste to realize its long-term goal of servicing the entire East Coast, from Florida to New York.
National Waste is a vertically-integrated waste management company offering landfill, transfer station, garbage collection and container services for both commercial entities and residential customers in Central Florida and Upstate New York. The company presently services the counties of Citrus, Hernando, and Marion in Florida and Upstate New York with 13 roll-off trucks and approximately 800 containers.
For more information, visit the company’s website at www.nationalwastemgmt.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
National Waste operates a licensed 54-acre landfill in Hernando, Florida, that disposes of roughly 240,000 cubic yards of construction debris annually. These landfill services include the disposal of asphalt and rock; lumber and wood; brick; wallboard, drywall and plaster; pallets; rock concrete; dirt, sand and uncontaminated soil; plumbing fixtures; non-asbestos insulation; roofing materials and shingles; glass; piping; waste metal; brush and land clearing; yard and tree waste; and many electrical and wiring components.
However, as extensive as those facilities are, they do not encompass the whole range of landfill services. There’s a lot more to garbage disposal than meets the eye.
Solid waste, defined as household garbage and industrial non-hazardous waste, is disposed of in a variety of landfills. Municipal solid waste landfills (MSWLF) are designed to accommodate the disposal of household waste but may accept other types of non-hazardous wastes, such as commercial solid waste, non-hazardous sludge, and industrial non-hazardous solid waste. A special kind of MSWLF is the bioreactor landfill, designed to degrade waste in a controlled manner.
Even though some commercial solid waste and industrial non-hazardous solid waste ends up in MSWLFs, there are special facilities, known as industrial waste landfills, designed to take commercial and institutional waste. In this category are construction and demolition (C&D) debris landfills, designed exclusively for construction and demolition materials, which consist of the debris generated during the construction, renovation and demolition of buildings, roads and bridges. C&D materials are typically bulky, heavy materials, such as concrete, wood, metals, glass and salvaged building components.
Another type of industrial waste landfill is the coal combustion residual (CCR) landfill, which is meant to accommodate coal ash and other residuals from coal combustion.
With such a heterogeneous landscape, there is ample opportunity for National Waste to continue the implementation of its vertical integration strategy. Apart from its landfill services, the company rents out roll-off containers of 20, 30 and 40 cubic yard capacity. It also offers recycled wood mulch and garden mulch products. The route is clear for National Waste to realize its long-term goal of servicing the entire East Coast, from Florida to New York.
National Waste is a vertically-integrated waste management company offering landfill, transfer station, garbage collection and container services for both commercial entities and residential customers in Central Florida and Upstate New York. The company presently services the counties of Citrus, Hernando, and Marion in Florida and Upstate New York with 13 roll-off trucks and approximately 800 containers.
For more information, visit the company’s website at www.nationalwastemgmt.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Friday, January 13, 2017
DelMar Pharmaceuticals (NASDAQ: DMPI) Given a ‘Buy’ Rating and $16 Price Target by Aegis Capital
Biotechnology company DelMar Pharmaceuticals (NASDAQ: DMPI) has been given a ‘Buy’ rating by Aegis Capital Corp. and a $16 price target (http://dtn.fm/jZlI7). The company was trading at $3.29 on January 11, 2016. To reach that price target, Aegis, in its initiation of coverage, said that it applied a 15x multiple after estimating the company’s 2022 EPS at $3.93, then discounting it by 30%.
DelMar Pharmaceuticals has been developing its lead product candidate, VAL-083, as a chemotherapy for cancer. Specifically, VAL-083 would be used in the treatment of glioblastoma multiforme (GBM), the most common form of a fatal and aggressive brain cancer. VAL-083 is a very different drug from other cancer medications. It avoids the repair activities that enable tumor cells to impede the impact of chemotherapy.
As a result, DelMar has an upcoming phase III trial in refractory GBM and two additional phase II studies anticipated to begin this year. VAL-083 will also be tested in the treatment of solid tumors and lung cancer, with phase I and II trials anticipated in 2017, the report stated. The report was signed by Robert LeBoyer, research analyst at Aegis, who added that Aegis expects DelMar Pharmaceuticals “to be driven” by these trials.
In its report, Aegis said that the phase III study is expected in late 1Q17 and should take place at major medicine centers, aiding enrollment. Further, it said that the Food & Drug Administration (FDA) believes that only one phase III study will be required for VAL-083, following its assessment of the results of completed phase I and II studies.
In 2016, DelMar completed its phase I/II trials of VAL-083, the report stated, and then met with the FDA. The FDA agreed that only one phase III trial would be necessary, because the company would then use a 505(b)(2) regulatory pathway. Aegis notes that this was a ‘significant development’, which may mean phase III results as early as 2019 ahead of approval in 2020.
On January 9, 2017, DelMar Pharmaceuticals received an increase in funding of up to CDN$413,000 from the National Research Council of Canada Industrial Research Assistance Program (NCR-IRAP) to support ongoing research of VAL-083 (http://dtn.fm/iWzk2). In conjunction with the BC Cancer Agency, Vancouver Prostate Centre and the University of British Columbia, research will continue, DelMar Pharmaceuticals announced.
“We are very pleased with NCR-IRAP’s continued support of our non-clinical research of our lead product candidate VAL-083,” Jeffrey Bacha, chairman and CEO of DelMar Pharmaceuticals, noted in the news release.
In its most recent 10-Q filing, DelMar Pharmaceuticals reported cash and cash equivalents of $4,799,033 (http://dtn.fm/5qecY). For the quarter ended June 30, 2016, the company reported to the SEC that it had raised $7.2 million from the sale of convertible preferred stock.
For more information, visit www.DelMarPharma.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
DelMar Pharmaceuticals has been developing its lead product candidate, VAL-083, as a chemotherapy for cancer. Specifically, VAL-083 would be used in the treatment of glioblastoma multiforme (GBM), the most common form of a fatal and aggressive brain cancer. VAL-083 is a very different drug from other cancer medications. It avoids the repair activities that enable tumor cells to impede the impact of chemotherapy.
As a result, DelMar has an upcoming phase III trial in refractory GBM and two additional phase II studies anticipated to begin this year. VAL-083 will also be tested in the treatment of solid tumors and lung cancer, with phase I and II trials anticipated in 2017, the report stated. The report was signed by Robert LeBoyer, research analyst at Aegis, who added that Aegis expects DelMar Pharmaceuticals “to be driven” by these trials.
In its report, Aegis said that the phase III study is expected in late 1Q17 and should take place at major medicine centers, aiding enrollment. Further, it said that the Food & Drug Administration (FDA) believes that only one phase III study will be required for VAL-083, following its assessment of the results of completed phase I and II studies.
In 2016, DelMar completed its phase I/II trials of VAL-083, the report stated, and then met with the FDA. The FDA agreed that only one phase III trial would be necessary, because the company would then use a 505(b)(2) regulatory pathway. Aegis notes that this was a ‘significant development’, which may mean phase III results as early as 2019 ahead of approval in 2020.
On January 9, 2017, DelMar Pharmaceuticals received an increase in funding of up to CDN$413,000 from the National Research Council of Canada Industrial Research Assistance Program (NCR-IRAP) to support ongoing research of VAL-083 (http://dtn.fm/iWzk2). In conjunction with the BC Cancer Agency, Vancouver Prostate Centre and the University of British Columbia, research will continue, DelMar Pharmaceuticals announced.
“We are very pleased with NCR-IRAP’s continued support of our non-clinical research of our lead product candidate VAL-083,” Jeffrey Bacha, chairman and CEO of DelMar Pharmaceuticals, noted in the news release.
In its most recent 10-Q filing, DelMar Pharmaceuticals reported cash and cash equivalents of $4,799,033 (http://dtn.fm/5qecY). For the quarter ended June 30, 2016, the company reported to the SEC that it had raised $7.2 million from the sale of convertible preferred stock.
For more information, visit www.DelMarPharma.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
MassRoots, Inc. (MSRT) Achieves Incredible Growth in 2016
MassRoots, Inc. (OTCQB: MSRT), a company offering cannabis enthusiasts the chance to share their cannabis content while staying connected with news and the latest legislation regarding the drug through a specialized social media platform and iOS application, has shown significant growth in the rapidly developing cannabis industry.
According to a SeeThruEquity update (http://dtn.fm/Y0Har), MassRoots achieved phenomenal growth in 2016, with revenue reaching $794,621 during the first three quarters of 2016, compared to just $63,982 during the same period of the previous year. This performance was attributed to the company’s ability to monetize its users, which increased by 1,140% as compared to the first three quarters of 2015.
The company now has a fan base of over 900,000 users and plans to introduce a range of new features to its platform, fully indexing the network’s public content on Google for search engine optimization purposes. Earlier this week, MassRoots launched an update to its iOS mobile application (http://dtn.fm/W8YeE), which is currently available through the App store. New features include geo-targeted advertisements, in-depth strain and product pages, and revamped reporting and content screening mechanisms.
In addition, MassRoots kicked off 2017 by achieving its strongest cash position in corporate history following the reception of $2 million in proceeds from the exercise of warrants (http://dtn.fm/bUC0G). According to CEO Isaac Dietrich, this capital infusion will allow MassRoots to continue building momentum in the industry. Dietrich has set an intermediate goal of reaching revenue levels similar to industry leaders such as Weedmaps and Leafly, which generated more than $25 million and $15 million in 2016 sales, respectively.
MassRoots’ substantial 2016 growth seems to be widely supported by strong industry trends. With eight states having legalized the recreational use of marijuana, MassRoots is positioned for growth, anticipating an increase in users from a number of states. Currently, the company receives three-quarters of its revenue from California and Colorado, but new markets are expected to emerge.
MassRoots also recently acquired DDDigtal, known as Whaxy, a menu management and online ordering platform for licensed cannabis businesses. In a news release announcing the acquisition (http://dtn.fm/zLsj0), Isaac Dietrich commented, “This acquisition, when completed, will expand MassRoots’ offerings to include a full suite of dispensary software solutions – online ordering, marketing, and real-time inventory management — for cannabis businesses”.
For more information, visit www.MassRoots.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
According to a SeeThruEquity update (http://dtn.fm/Y0Har), MassRoots achieved phenomenal growth in 2016, with revenue reaching $794,621 during the first three quarters of 2016, compared to just $63,982 during the same period of the previous year. This performance was attributed to the company’s ability to monetize its users, which increased by 1,140% as compared to the first three quarters of 2015.
The company now has a fan base of over 900,000 users and plans to introduce a range of new features to its platform, fully indexing the network’s public content on Google for search engine optimization purposes. Earlier this week, MassRoots launched an update to its iOS mobile application (http://dtn.fm/W8YeE), which is currently available through the App store. New features include geo-targeted advertisements, in-depth strain and product pages, and revamped reporting and content screening mechanisms.
In addition, MassRoots kicked off 2017 by achieving its strongest cash position in corporate history following the reception of $2 million in proceeds from the exercise of warrants (http://dtn.fm/bUC0G). According to CEO Isaac Dietrich, this capital infusion will allow MassRoots to continue building momentum in the industry. Dietrich has set an intermediate goal of reaching revenue levels similar to industry leaders such as Weedmaps and Leafly, which generated more than $25 million and $15 million in 2016 sales, respectively.
MassRoots’ substantial 2016 growth seems to be widely supported by strong industry trends. With eight states having legalized the recreational use of marijuana, MassRoots is positioned for growth, anticipating an increase in users from a number of states. Currently, the company receives three-quarters of its revenue from California and Colorado, but new markets are expected to emerge.
MassRoots also recently acquired DDDigtal, known as Whaxy, a menu management and online ordering platform for licensed cannabis businesses. In a news release announcing the acquisition (http://dtn.fm/zLsj0), Isaac Dietrich commented, “This acquisition, when completed, will expand MassRoots’ offerings to include a full suite of dispensary software solutions – online ordering, marketing, and real-time inventory management — for cannabis businesses”.
For more information, visit www.MassRoots.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Wednesday, January 11, 2017
Cytosorbents Corp. (NASDAQ: CTSO) Expected to Announce Doubling in Sales for 2016
Cytosorbents Corp. (NASDAQ: CTSO), a critical care-focused immunotherapy company engaged in the research, development, and commercialization of medical devices, most prominently its platform blood purification technology that incorporates a proprietary adsorbent polymer technology, recently pre-announced unaudited results (http://dtn.fm/bKG3F) for fiscal 2016 ahead of its Form 10-K filing.
Cytosorbents expects to announce between $8.1 and $8.3 million in Cytosorb sales for the whole of 2016. This equates to more than double the total from the previous year. Cytosorb is the company’s flagship product, a blood filter that helps treat deadly inflammation in critically-ill and cardiac surgery patients across the globe.
In addition to this, the company predicts product sales for the fourth quarter of 2016 to range between $2.5 and $2.7 million, compared to just $1.5 million during the fourth quarter of 2015. This will take Cytosorbents to its sixth consecutive quarter reporting record sales, with the result representing a 20% increase as compared to the third quarter of 2016.
Cytosorbents Corp. had its ‘Buy’ rating reaffirmed by equities and research analysts at HC Wainwright, B. Riley, Maxim Group, Brean Capital, and Aegis Capital Corp., all according to Daily Quint (http://dtn.fm/80qqY). Currently, the consensus target price for the company is $15.05 per share. Not only this, Advisor Group, Inc. raised its position in Cytosorbents’ stock by over 1% during the third quarter, giving it ownership of 1.20% of the company’s stock worth over $1.9 million.
Cytosorbents Corp. also announced that it is expanding its partnership with Fresenius Medical Care (FMC) (http://dtn.fm/biF1L), the world’s largest dialysis company, increasing the commitment to a three-year renewal and a guaranteed minimum order of Cytosorb. The expansion also includes the addition of a new co-marketing agreement for worldwide Cytosorb markets.
For more information, visit www.Cytosorbents.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Cytosorbents expects to announce between $8.1 and $8.3 million in Cytosorb sales for the whole of 2016. This equates to more than double the total from the previous year. Cytosorb is the company’s flagship product, a blood filter that helps treat deadly inflammation in critically-ill and cardiac surgery patients across the globe.
In addition to this, the company predicts product sales for the fourth quarter of 2016 to range between $2.5 and $2.7 million, compared to just $1.5 million during the fourth quarter of 2015. This will take Cytosorbents to its sixth consecutive quarter reporting record sales, with the result representing a 20% increase as compared to the third quarter of 2016.
Cytosorbents Corp. had its ‘Buy’ rating reaffirmed by equities and research analysts at HC Wainwright, B. Riley, Maxim Group, Brean Capital, and Aegis Capital Corp., all according to Daily Quint (http://dtn.fm/80qqY). Currently, the consensus target price for the company is $15.05 per share. Not only this, Advisor Group, Inc. raised its position in Cytosorbents’ stock by over 1% during the third quarter, giving it ownership of 1.20% of the company’s stock worth over $1.9 million.
Cytosorbents Corp. also announced that it is expanding its partnership with Fresenius Medical Care (FMC) (http://dtn.fm/biF1L), the world’s largest dialysis company, increasing the commitment to a three-year renewal and a guaranteed minimum order of Cytosorb. The expansion also includes the addition of a new co-marketing agreement for worldwide Cytosorb markets.
For more information, visit www.Cytosorbents.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Aegis Restates ‘Buy’ Rating on Shares of Rosetta Genomics Ltd. (NASDAQ: ROSG)
Rosetta Genomics, Ltd. (NASDAQ: ROSG), a company in the business of developing and commercializing MicroRNA-based and other molecular diagnostics, recently had its ‘Buy’ rating restated by Aegis Capital Corp. (http://dtn.fm/l0Yk0) with a price target of $3.50 per share. This was based on Aegis’ 2017 revenue estimate of $17.7 million with a multiple of 4X. The company update was released after Rosetta Genomics Ltd. announced a new collaboration to determine biomarkers that can predict response to Opdivo, a PD-1 immunotherapy.
In addition to the above, Aegis Capital Corp. announced expectations for Rosetta Genomics’ cash deliverables to be over $9 million by the end of this year after the company completed a financing with stock and convertible debentures of approximately $5 million. This is accompanied by the fact that Rosetta Genomics continues to expand its portfolio of diagnostic tests through collaborations, allowing it to grow its business and expand its client base.
The company reported an increase in revenue from $2.3 million in 1H15 to $5 million during the first six months of 2016. This has been put down to a growing demand for RosettaGX Reveal for thyroid, for which revenues were expected to reach approximately $1.5 million by the end of September 30, 2016, according to the report. Not only this, total expenses were lower than Aegis’ estimates, showcasing the company’s ability to efficiently manage its cash.
Since Aegis initiated coverage on Rosetta Genomics, the company has grown from a single diagnostic to a portfolio covering solid tumors, urology, and thyroid cancer. Aegis estimates the company’s product revenue to be $10.8 million for the full year with allowance for variations in revenue recognition and COGS, which is currently estimated at 85% of the revenue level seen in previous quarters.
Aside from the company’s ability to continue to make progress in product development, sales growth, and financial advancements, Aegis expects Rosetta to continue to increase its sales and customer base. According to Community Financial News (http://dtn.fm/xES6P), institutional investor Morgan Stanley recently increased its stake in Rosetta Genomics Ltd. by 15%, giving it ownership of just under 338,000 shares of the company’s stock. Hedge funds and institutional investors now own just below 4.3% of the company’s stock.
For more information, visit www.RosettaGx.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
In addition to the above, Aegis Capital Corp. announced expectations for Rosetta Genomics’ cash deliverables to be over $9 million by the end of this year after the company completed a financing with stock and convertible debentures of approximately $5 million. This is accompanied by the fact that Rosetta Genomics continues to expand its portfolio of diagnostic tests through collaborations, allowing it to grow its business and expand its client base.
The company reported an increase in revenue from $2.3 million in 1H15 to $5 million during the first six months of 2016. This has been put down to a growing demand for RosettaGX Reveal for thyroid, for which revenues were expected to reach approximately $1.5 million by the end of September 30, 2016, according to the report. Not only this, total expenses were lower than Aegis’ estimates, showcasing the company’s ability to efficiently manage its cash.
Since Aegis initiated coverage on Rosetta Genomics, the company has grown from a single diagnostic to a portfolio covering solid tumors, urology, and thyroid cancer. Aegis estimates the company’s product revenue to be $10.8 million for the full year with allowance for variations in revenue recognition and COGS, which is currently estimated at 85% of the revenue level seen in previous quarters.
Aside from the company’s ability to continue to make progress in product development, sales growth, and financial advancements, Aegis expects Rosetta to continue to increase its sales and customer base. According to Community Financial News (http://dtn.fm/xES6P), institutional investor Morgan Stanley recently increased its stake in Rosetta Genomics Ltd. by 15%, giving it ownership of just under 338,000 shares of the company’s stock. Hedge funds and institutional investors now own just below 4.3% of the company’s stock.
For more information, visit www.RosettaGx.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Trevena, Inc. (NASDAQ: TRVN) Completes Phase 3 Apollo Trials for Oliceridine, Says Athena Study on Track
Trevena, Inc. (NASDAQ: TRVN), a clinical stage biopharmaceutical company, on January 4 announced it had completed enrollment for its Phase 3 Apollo Pivotal Efficacy Trials of oliceridine for moderate to severe pain.
Oliceridine (TRV 130) is Trevena’s lead product candidate. It was deemed “a breakthrough therapy by the U.S. Food and Drug Administration,” based on the results of earlier clinical trials, the company said (http://dtn.fm/5zmYr).
“We are pleased to have completed enrollment in these important studies and to confirm that the Apollo trials remain on schedule to report top-line results in the first quarter of 2017,” Maxine Gowen, Ph.D., chief executive officer of Trevena, stated in a news release. “We look forward to sharing these data when they become available.”
Trevena expects that, compared to morphine and placebo, these results will show that oliceridine shows tolerability, safety and efficacy. Additionally, Trevena announced that patient enrollment for its Phase 3 Athena safety study is on track.
The company noted plans to file a New Drug Application (NDA) for oliceridine with the U.S. Food & Drug Administration in the second half of this year.
Trevena also has a portfolio, in the early stages, of more drug discovery programs. The company has also discovered additional drugs, such as TRV027 for acute heart failure, TRV734 for pain and TRV250 for migraine.
In its 10-Q Securities and Exchange Commission filing for November 2016, Trevena reported revenues of $3.75 million for the nine-month period ended September 30, 2016 (http://dtn.fm/hf4AH). By comparison, its revenue was $4.375 million for the same period a year earlier.
In an 8-K filing on January 4, 2017, Trevena reported that its net cash on hand should fund its operations until at least March 31, 2018. The company had cash equivalents, cash and marketable securities of $110.6 million as of December 31, 2016, the report said (http://dtn.fm/6OjhM).
Earlier this month, Aegis Capital Corp. gave Trevena a ‘Buy’ rating and a target price of $14 per share (http://dtn.fm/exE4N). Differ Yang, Ph.D., research analyst, said that the target price was determined through a DCF analysis. Aegis set a seven-time multiple of the 2022 EBITDA of $168 million. Yang said Aegis further assumed a clinical success probability of 70% for Trevena’s phase III program.
The company’s share price was $6.49 at market close on January 10, 2017, and its 52-week range was $10.00 – $3.76.
For more information, visit the company’s website at www.Trevena.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Oliceridine (TRV 130) is Trevena’s lead product candidate. It was deemed “a breakthrough therapy by the U.S. Food and Drug Administration,” based on the results of earlier clinical trials, the company said (http://dtn.fm/5zmYr).
“We are pleased to have completed enrollment in these important studies and to confirm that the Apollo trials remain on schedule to report top-line results in the first quarter of 2017,” Maxine Gowen, Ph.D., chief executive officer of Trevena, stated in a news release. “We look forward to sharing these data when they become available.”
Trevena expects that, compared to morphine and placebo, these results will show that oliceridine shows tolerability, safety and efficacy. Additionally, Trevena announced that patient enrollment for its Phase 3 Athena safety study is on track.
The company noted plans to file a New Drug Application (NDA) for oliceridine with the U.S. Food & Drug Administration in the second half of this year.
Trevena also has a portfolio, in the early stages, of more drug discovery programs. The company has also discovered additional drugs, such as TRV027 for acute heart failure, TRV734 for pain and TRV250 for migraine.
In its 10-Q Securities and Exchange Commission filing for November 2016, Trevena reported revenues of $3.75 million for the nine-month period ended September 30, 2016 (http://dtn.fm/hf4AH). By comparison, its revenue was $4.375 million for the same period a year earlier.
In an 8-K filing on January 4, 2017, Trevena reported that its net cash on hand should fund its operations until at least March 31, 2018. The company had cash equivalents, cash and marketable securities of $110.6 million as of December 31, 2016, the report said (http://dtn.fm/6OjhM).
Earlier this month, Aegis Capital Corp. gave Trevena a ‘Buy’ rating and a target price of $14 per share (http://dtn.fm/exE4N). Differ Yang, Ph.D., research analyst, said that the target price was determined through a DCF analysis. Aegis set a seven-time multiple of the 2022 EBITDA of $168 million. Yang said Aegis further assumed a clinical success probability of 70% for Trevena’s phase III program.
The company’s share price was $6.49 at market close on January 10, 2017, and its 52-week range was $10.00 – $3.76.
For more information, visit the company’s website at www.Trevena.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
eXp World Holdings, Inc. (EXPI) Subsidiary eXp Realty Records 178% Increase in Agent Count During 2016
Before the opening bell, eXp World Holdings, Inc. (OTCQB: EXPI) announced final 2016 agent totals for subsidiary eXp Realty LLC, the Agent-Owned Cloud Brokerage®. With 2,401 real estate brokers and agents on its platform at the end of the year, the company achieved a year-over-year increase of 178 percent, or 1,537 members, during 2016. This growth was driven, in part, by eXp Realty’s continued geographic expansion. The company currently operates in 42 states, the District of Columbia and Alberta, Canada. Likewise, in this morning’s update, EXPI attributed the success of eXp Realty to its “unique agent-centric model that allows agents and brokers to build their own businesses, while establishing a direct ownership interest” in the company, as both a shareholder and an operating partner.
“Our rapid growth in 2016 not only exceeded our goal of 2,200 agents by year-end, but also established us as one of the fastest growing brokerages in North America,” Glenn Sanford, founder, chairman and CEO of EXPI, stated in the news release. “Our model has resonated with quality real estate professionals, allowing us to attract some of the top producing agents as well as some of the highest ranking teams throughout the U.S. and Canada.”
In the fourth quarter of 2016 alone, eXp Realty announced the additions of a number of leading real estate professionals to its growing ranks. These included Miguel Herrera, the top luxury agent in all of South Texas; the Brent Gove team, one of the top real estate teams in California; Darren James Real Estate Experts, which was ranked just outside of the top 50 nationally in terms of 2015 transactions by the Wall Street Journal; and Burch & Co. Real Estate, the top brokerage in Northeast Arkansas.
eXp Realty’s innovative approach to the real estate industry also garnered attention from a collection of high-profile media outlets in 2016, with the company being named a ‘Top Workplace’ by The Oklahoman newspaper in December. eXp Realty received similar recognition from both The Washington Post and The Atlanta Journal-Constitution earlier in the year.
The company kicked off 2017 by strengthening its leadership team, appointing industry veteran Laurie Hawkes as an independent director of eXp Realty. Hawkes brings nearly four decades of experience to the Agent-Owned Cloud Brokerage®, having previously served as president and head of acquisitions for U.S. Realty Advisors, a $3 billion real estate private equity firm operating in New York City. Leaning on the combined expertise and experience of its management team and board of directors, EXPI will look to build on its strong 2016 growth while continuing to drive innovation in the evolving real estate industry.
“Looking ahead to 2017, we expect to continue our accelerated growth rate in both agent count and revenues as a result of our unique commitment to agent ownership, support and engagement,” concluded Sanford.
For more information, visit the company’s website at www.eXpWorldHoldings.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
“Our rapid growth in 2016 not only exceeded our goal of 2,200 agents by year-end, but also established us as one of the fastest growing brokerages in North America,” Glenn Sanford, founder, chairman and CEO of EXPI, stated in the news release. “Our model has resonated with quality real estate professionals, allowing us to attract some of the top producing agents as well as some of the highest ranking teams throughout the U.S. and Canada.”
In the fourth quarter of 2016 alone, eXp Realty announced the additions of a number of leading real estate professionals to its growing ranks. These included Miguel Herrera, the top luxury agent in all of South Texas; the Brent Gove team, one of the top real estate teams in California; Darren James Real Estate Experts, which was ranked just outside of the top 50 nationally in terms of 2015 transactions by the Wall Street Journal; and Burch & Co. Real Estate, the top brokerage in Northeast Arkansas.
eXp Realty’s innovative approach to the real estate industry also garnered attention from a collection of high-profile media outlets in 2016, with the company being named a ‘Top Workplace’ by The Oklahoman newspaper in December. eXp Realty received similar recognition from both The Washington Post and The Atlanta Journal-Constitution earlier in the year.
The company kicked off 2017 by strengthening its leadership team, appointing industry veteran Laurie Hawkes as an independent director of eXp Realty. Hawkes brings nearly four decades of experience to the Agent-Owned Cloud Brokerage®, having previously served as president and head of acquisitions for U.S. Realty Advisors, a $3 billion real estate private equity firm operating in New York City. Leaning on the combined expertise and experience of its management team and board of directors, EXPI will look to build on its strong 2016 growth while continuing to drive innovation in the evolving real estate industry.
“Looking ahead to 2017, we expect to continue our accelerated growth rate in both agent count and revenues as a result of our unique commitment to agent ownership, support and engagement,” concluded Sanford.
For more information, visit the company’s website at www.eXpWorldHoldings.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Tuesday, January 10, 2017
Popular Travel Destinations in 2017 among Monaker Group (MKGI) Tour Offerings
This year’s list of popular travel destinations is already quite varied and includes something for every demographic, from exciting adventures to classic cultural events and more. Whether it’s going on an African safari or visiting some of the oldest museums in Europe, tourists can easily organize their journeys with a little help from Monaker Group, Inc. (OTCQB: MKGI) and its subsidiaries: NextTrip.com, a real-time booking platform, and Maupintour, a provider of personalized tours.
According to Lonely Planet’s ‘Best in Travel 2017′ guide (http://dtn.fm/K5RHc), the top 10 list of countries that should be visited this year is led by none other than Canada. The United States’ neighbor to the north has long been a popular destination with many Americans and other foreign tourists alike, with its fusion cuisine, impressive wine offerings and international reputation for politeness and inclusiveness. This year promises to offer visitors an exceptional celebration, as the world’s second largest country will mark 150 years since its confederation. Expect some of the biggest parties the country has ever seen all throughout the year, but the festivities are likely to peak around July 1, when the actual sesquicentennial is celebrated.
Another popular destination in 2017 is Colombia. The South American state has overcome its violent past, marked by crime and civil unrest, and is now a welcoming place for overseas travelers, offering a unique blend of hospitality, beautiful nature and vibrant culture. Colombia expects a papal visit this year – the first in 30 years, which seems very likely to drive a significant portion of the country’s overall travel market. The third country on Lonely Planet’s list is Finland, which has a wealth of events planned this year in honor of its centenary. From lively concerts and culinary festivals to winter sports championships and the opening of a new national park, Finland has something for every traveler looking to have a great time discovering a unique landscape and culture. The list of popular countries to visit this year also includes many exotic destinations, such as Dominica, Myanmar, and Ethiopia, as well as challenging travel places such as Nepal and Mongolia.
Travelers can plan and organize their journeys to any of these top three destinations and many others with the help of Monaker Group, a technology-driven tourism company offering comprehensive travel solutions and personalized tours. Via its flagship company NextTrip.com, Monaker allows tourists to plan their trips to the smallest details by offering them real-time access to everything they need for an ideal travel experience, from alternative lodging rental options to hotels, airlines, rental car services, concierge services and more. The NextTrip.com platform is representative of the group’s focus on the alternative lodging rental market, offering access to more than 1.1 million units worldwide. The platform is also the first and only that offers comprehensive real-time booking options to meet tourists’ every need.
Tours are organized through Maupintour, a leading provider of luxury travel services with a strong reputation for creating unique itineraries and offering outstanding service. This commitment to excellence has helped the brand achieve one of the highest repeat customer rates in the industry.
For more information, visit www.MonakerGroup.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
According to Lonely Planet’s ‘Best in Travel 2017′ guide (http://dtn.fm/K5RHc), the top 10 list of countries that should be visited this year is led by none other than Canada. The United States’ neighbor to the north has long been a popular destination with many Americans and other foreign tourists alike, with its fusion cuisine, impressive wine offerings and international reputation for politeness and inclusiveness. This year promises to offer visitors an exceptional celebration, as the world’s second largest country will mark 150 years since its confederation. Expect some of the biggest parties the country has ever seen all throughout the year, but the festivities are likely to peak around July 1, when the actual sesquicentennial is celebrated.
Another popular destination in 2017 is Colombia. The South American state has overcome its violent past, marked by crime and civil unrest, and is now a welcoming place for overseas travelers, offering a unique blend of hospitality, beautiful nature and vibrant culture. Colombia expects a papal visit this year – the first in 30 years, which seems very likely to drive a significant portion of the country’s overall travel market. The third country on Lonely Planet’s list is Finland, which has a wealth of events planned this year in honor of its centenary. From lively concerts and culinary festivals to winter sports championships and the opening of a new national park, Finland has something for every traveler looking to have a great time discovering a unique landscape and culture. The list of popular countries to visit this year also includes many exotic destinations, such as Dominica, Myanmar, and Ethiopia, as well as challenging travel places such as Nepal and Mongolia.
Travelers can plan and organize their journeys to any of these top three destinations and many others with the help of Monaker Group, a technology-driven tourism company offering comprehensive travel solutions and personalized tours. Via its flagship company NextTrip.com, Monaker allows tourists to plan their trips to the smallest details by offering them real-time access to everything they need for an ideal travel experience, from alternative lodging rental options to hotels, airlines, rental car services, concierge services and more. The NextTrip.com platform is representative of the group’s focus on the alternative lodging rental market, offering access to more than 1.1 million units worldwide. The platform is also the first and only that offers comprehensive real-time booking options to meet tourists’ every need.
Tours are organized through Maupintour, a leading provider of luxury travel services with a strong reputation for creating unique itineraries and offering outstanding service. This commitment to excellence has helped the brand achieve one of the highest repeat customer rates in the industry.
For more information, visit www.MonakerGroup.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Jaguar Animal Health, Inc. (NASDAQ: JAGX) Given Company Update by Aegis Capital Corp.
Jaguar Animal Health, Inc. (NASDAQ: JAGX), a company in the business of developing and commercializing gastrointestinal products for companion animals, horses, and production animals, recently had its company outlook updated by Aegis Capital Corp. (http://dtn.fm/Phj8l). The company has been offered a ‘Buy’ rating with a price target of $10 per share. The company update was announced after JAGX made several decisions that Aegis believes could improve the outlook for the company.
The company, which is committed to identifying animal health market opportunities to develop products specific to various species, announced that it has proposed a business combination with its parent company, Napo Therapeutics, Inc., to form a single entity. This, combined with Napo’s recent reacquisition of anti-diarrhea drug crofelemer from Valeant Pharmaceuticals (NYSE: VRX), will consolidate all human and animal health operations into one company.
In addition to the above, Jaguar Animal Health, Inc. recently announced a product distribution agreement with Henry Schein, Inc. (NASDAQ: HSIC) for Neonorm Foal, a form of crofelemer used to treat newborn horses with diarrhea. This agreement will allow crofelemer to be distributed more widely thanks to Schein’s Animal Health Division, which has a client base of 26,000 veterinary professionals. Not only will the product be distributed across all segments of the U.S. equine market, but Jaguar will also be given more time to focus its efforts on developing new therapeutics.
Aegis Capital Corp. is not the only research analyst showing an interest in Jaguar Animal Health, Inc. Most recently, the company received a consensus ‘Buy’ rating, with one equity research analyst rating the stock with a ‘Buy’ recommendation and another with a ‘Strong Buy’ recommendation. According to the Cerbat Gem Market News and Analysis (http://dtn.fm/6roMM), Zacks Investment Research has assigned JAGX an industry rank of 64 out of 265, and brokers have set a price objective of $6.50 for the following 12 months. As of close of market January 9, 2016, Jaguar was trading at $0.66 per share.
For more information, visit www.JaguarAnimalHealth.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
The company, which is committed to identifying animal health market opportunities to develop products specific to various species, announced that it has proposed a business combination with its parent company, Napo Therapeutics, Inc., to form a single entity. This, combined with Napo’s recent reacquisition of anti-diarrhea drug crofelemer from Valeant Pharmaceuticals (NYSE: VRX), will consolidate all human and animal health operations into one company.
In addition to the above, Jaguar Animal Health, Inc. recently announced a product distribution agreement with Henry Schein, Inc. (NASDAQ: HSIC) for Neonorm Foal, a form of crofelemer used to treat newborn horses with diarrhea. This agreement will allow crofelemer to be distributed more widely thanks to Schein’s Animal Health Division, which has a client base of 26,000 veterinary professionals. Not only will the product be distributed across all segments of the U.S. equine market, but Jaguar will also be given more time to focus its efforts on developing new therapeutics.
Aegis Capital Corp. is not the only research analyst showing an interest in Jaguar Animal Health, Inc. Most recently, the company received a consensus ‘Buy’ rating, with one equity research analyst rating the stock with a ‘Buy’ recommendation and another with a ‘Strong Buy’ recommendation. According to the Cerbat Gem Market News and Analysis (http://dtn.fm/6roMM), Zacks Investment Research has assigned JAGX an industry rank of 64 out of 265, and brokers have set a price objective of $6.50 for the following 12 months. As of close of market January 9, 2016, Jaguar was trading at $0.66 per share.
For more information, visit www.JaguarAnimalHealth.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Strong Residential Real Estate Market Bodes Well For eXp World Holdings, Inc. (EXPI)
The market for residential real estate is projected to be strong in 2017 and 2018 by numerous real estate organizations, and that can only be bullish news for Bellingham, Washington-based eXp World Holdings, Inc. (OTCQB: EXPI), the holding company for eXp Realty LLC, the Agent-Owned Cloud Brokerage®.
The National Association of Realtors® (NAR) and the National Association of Home Builders® (NAHB) agree that there will be an increase in both existing and new home sales. They may not share the same base numbers in residential real estate, but they both expect positive growth in the two-year period ahead.
Lawrence Yun, chief economist for NAR, expects existing home sales to grow 2% in 2017 to about 5.46 million (http://dtn.fm/LrUu2). Then, this figure will grow by another 4% in 2018 to 5.68 million, he forecasts. Yun added that existing home prices will likely jump by 4% in 2017. This market performance will be driven by a combination of more millennials entering their prime home buying years, rising household formation and job gains, he said. Yun also anticipates housing starts to jump 5.3% in 2017 to 1.22 million.
NAHB (www.nahb.org) sees housing total starts growing by 6.6% from 1.162 million in 2016 to 1.239 million in 2017, and another 7.5% to 1.332 million in 2018. Starts for single family homes will grow from 780,000 in 2016 to 855,000 in 2017 and 961,000 in 2018 — a two-year jump of 23%. New single family home sales will grow from 565,000 in 2016 to 630,000 in 2017 and 708,000 in 2018, the group predicts. Forecasts call for sales of existing family homes to grow by 2.6% from 4,832 in 2016 to 4,960 in 2018.
Additionally, Zillow’s Real Estate Market Report for October 2016 reported that U.S. median home values were up by 6.2% in 2016 (http://dtn.fm/pDFe0). Zillow projects that rally will cool down to a 3% appreciation increase by late 2017. A majority of housing experts told Zillow in its Home Price Expectations Survey that the trend to slowing home appreciation will also result in more inventory and a shift from a seller’s market to a buyer’s market in 2018 or 2019. Zillow’s Chief Economist, Dr. Svenja Gudell, said, “As the number of homes for sale increases and home value appreciation slows, we expect the market to meaningfully swing in favor of buyers within the next two to three years.”
To eXp World Holdings, Inc., as well as subsidiary eXp Realty, LLC, the projections of a strong real estate housing market in 2017 and 2018 are good news. If those projections hold up, it will mean more sales of both existing and new homes over the next two years in a vibrant new and existing homes market.
In its 10-Q filing of September 30, 2016, eXp World Holdings, Inc., reported nine-month revenues of $36,181,796, a 119% increase from revenues of $16,453,307 a year earlier. For its quarter ended September 30, 2016, sales rose 112% to $15,756,956 from $7,419,103 the previous year.
eXp Realty is a cloud-based real estate brokerage operating in 41 states, the District of Columbia and Alberta, Canada. Without the margin-eroding costs of physical brick and mortar offices or redundant staffing expenses, the cloud-focused brokerage network has attracted some 1,900 leading agents and brokers operating across North America. eXp Realty, as a full service real estate brokerage, offers 24/7 access to collaborative tools, training and socialization for real estate brokers and agents through its 3D, fully immersive, cloud office environment.
For more information, visit the company’s website at www.eXpWorldHoldings.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
The National Association of Realtors® (NAR) and the National Association of Home Builders® (NAHB) agree that there will be an increase in both existing and new home sales. They may not share the same base numbers in residential real estate, but they both expect positive growth in the two-year period ahead.
Lawrence Yun, chief economist for NAR, expects existing home sales to grow 2% in 2017 to about 5.46 million (http://dtn.fm/LrUu2). Then, this figure will grow by another 4% in 2018 to 5.68 million, he forecasts. Yun added that existing home prices will likely jump by 4% in 2017. This market performance will be driven by a combination of more millennials entering their prime home buying years, rising household formation and job gains, he said. Yun also anticipates housing starts to jump 5.3% in 2017 to 1.22 million.
NAHB (www.nahb.org) sees housing total starts growing by 6.6% from 1.162 million in 2016 to 1.239 million in 2017, and another 7.5% to 1.332 million in 2018. Starts for single family homes will grow from 780,000 in 2016 to 855,000 in 2017 and 961,000 in 2018 — a two-year jump of 23%. New single family home sales will grow from 565,000 in 2016 to 630,000 in 2017 and 708,000 in 2018, the group predicts. Forecasts call for sales of existing family homes to grow by 2.6% from 4,832 in 2016 to 4,960 in 2018.
Additionally, Zillow’s Real Estate Market Report for October 2016 reported that U.S. median home values were up by 6.2% in 2016 (http://dtn.fm/pDFe0). Zillow projects that rally will cool down to a 3% appreciation increase by late 2017. A majority of housing experts told Zillow in its Home Price Expectations Survey that the trend to slowing home appreciation will also result in more inventory and a shift from a seller’s market to a buyer’s market in 2018 or 2019. Zillow’s Chief Economist, Dr. Svenja Gudell, said, “As the number of homes for sale increases and home value appreciation slows, we expect the market to meaningfully swing in favor of buyers within the next two to three years.”
To eXp World Holdings, Inc., as well as subsidiary eXp Realty, LLC, the projections of a strong real estate housing market in 2017 and 2018 are good news. If those projections hold up, it will mean more sales of both existing and new homes over the next two years in a vibrant new and existing homes market.
In its 10-Q filing of September 30, 2016, eXp World Holdings, Inc., reported nine-month revenues of $36,181,796, a 119% increase from revenues of $16,453,307 a year earlier. For its quarter ended September 30, 2016, sales rose 112% to $15,756,956 from $7,419,103 the previous year.
eXp Realty is a cloud-based real estate brokerage operating in 41 states, the District of Columbia and Alberta, Canada. Without the margin-eroding costs of physical brick and mortar offices or redundant staffing expenses, the cloud-focused brokerage network has attracted some 1,900 leading agents and brokers operating across North America. eXp Realty, as a full service real estate brokerage, offers 24/7 access to collaborative tools, training and socialization for real estate brokers and agents through its 3D, fully immersive, cloud office environment.
For more information, visit the company’s website at www.eXpWorldHoldings.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
National Waste Management Holdings, Inc. (NWMH) Services Focused on Creating a Greener, Better Tomorrow
Over the last few decades, proper waste disposal and management has become more important than ever, amid growing consumption and waste production, with potentially hazardous consequences for the environment. Despite environmental protection organizations and authorities’ recommendations, recycling efforts are still scarce, both on a residential and industrial level. In this landscape, professional waste management operators such as Florida-based National Waste Management Holdings, Inc. (OTC: NWMH) have taken on a bigger role in raising public awareness and ultimately working for a better and greener tomorrow via a comprehensive suite of waste disposal services ranging from pick-up to recycling and landfill operations.
It is estimated that the United States generates more than 250 million tons of municipal solid waste every year, and that an average person typically creates about four pounds of waste a day. According to Environmental Protection Agency data, about 75 percent of this waste stream is recyclable, yet only roughly 30 percent actually ends up being recycled. In addition to municipal solid waste, the U.S. also generates more than 500 tons of construction and demolition (C&D) debris every year – debris that needs to be disposed of in an eco-friendly manner.
National Waste Management Holdings is dedicated to recycling as much waste as possible from all of its services, with the primary goal of helping the State of Florida meet its mandate for 75 percent recycling by 2020. The company already offers a wide range of waste management services, most notably a 54-acre landfill in Hernando, Florida. The landfill services Hernando, Citrus and Marion counties and disposes of approximately 240,000 cubic yards of C&D debris every year. In addition to the landfill, National Waste Management Holdings also offers roll off waste container rental services, container drop off and pick up services and a line of proprietary mulch manufactured from recycled wood collected at its landfill and transfer station.
The company estimates that at least 12 percent of Florida’s 75 percent recycling mandate can be achieved by recycling C&D debris that is currently being disposed. For that purpose, National Waste Management Holdings has transformed its services and changed its fundamental business model, with plans in the coming year to set up a portable sorting line at its landfill and increase recyclable rates. The sorting line can help the company increase its concrete recycling program by an estimated 25 percent and also to pick clean dimensional lumber to be sold to wood pellet manufacturers. The sorting line also picks shrink wrap plastic and cardboard for recycling.
Working closely with the Florida Department of Environmental Protection and having a strong commitment to being environmentally conscious in all its activities and services, National Waste Management Holdings is positioning itself as a leading provider of waste and C&D debris management operations for both the commercial and the residential sectors. Currently servicing several counties on Florida’s west coast, the company has already expanded operations into New York, is collaborating with the State of Georgia, and has plans for further expansion all throughout the East Coast.
For more information, visit the company’s website at www.nationalwastemgmt.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
It is estimated that the United States generates more than 250 million tons of municipal solid waste every year, and that an average person typically creates about four pounds of waste a day. According to Environmental Protection Agency data, about 75 percent of this waste stream is recyclable, yet only roughly 30 percent actually ends up being recycled. In addition to municipal solid waste, the U.S. also generates more than 500 tons of construction and demolition (C&D) debris every year – debris that needs to be disposed of in an eco-friendly manner.
National Waste Management Holdings is dedicated to recycling as much waste as possible from all of its services, with the primary goal of helping the State of Florida meet its mandate for 75 percent recycling by 2020. The company already offers a wide range of waste management services, most notably a 54-acre landfill in Hernando, Florida. The landfill services Hernando, Citrus and Marion counties and disposes of approximately 240,000 cubic yards of C&D debris every year. In addition to the landfill, National Waste Management Holdings also offers roll off waste container rental services, container drop off and pick up services and a line of proprietary mulch manufactured from recycled wood collected at its landfill and transfer station.
The company estimates that at least 12 percent of Florida’s 75 percent recycling mandate can be achieved by recycling C&D debris that is currently being disposed. For that purpose, National Waste Management Holdings has transformed its services and changed its fundamental business model, with plans in the coming year to set up a portable sorting line at its landfill and increase recyclable rates. The sorting line can help the company increase its concrete recycling program by an estimated 25 percent and also to pick clean dimensional lumber to be sold to wood pellet manufacturers. The sorting line also picks shrink wrap plastic and cardboard for recycling.
Working closely with the Florida Department of Environmental Protection and having a strong commitment to being environmentally conscious in all its activities and services, National Waste Management Holdings is positioning itself as a leading provider of waste and C&D debris management operations for both the commercial and the residential sectors. Currently servicing several counties on Florida’s west coast, the company has already expanded operations into New York, is collaborating with the State of Georgia, and has plans for further expansion all throughout the East Coast.
For more information, visit the company’s website at www.nationalwastemgmt.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Monday, January 9, 2017
National Waste Management Holdings, Inc. (NWMH) Acquires Northeast Data Destruction and Recycling
Before the opening bell, National Waste Management Holdings, Inc. (OTC: NWMH) announced its acquisition of Northeast Data Destruction and Recycling, LLC, located in Kingston, New York. The transaction, which closed on December 31, 2016, continued to support the company’s aggressive acquisition strategy calling for at least one acquisition per quarter. Through this rapid strategic expansion, National Waste Management aims to effectively diversify its revenue streams while moving toward vertical integration.
“We are proud to announce our final acquisition of 2016, an achievement on par with our goal to become vertically integrated via strategic acquisition,” Dali Kranzthor, chief financial officer of National Waste Management, stated in this morning’s news release. “We have more acquisitions in the pipeline and look forward to another year of building value for National Waste and its shareholders.”
In addition to expanding its base operations in Upstate New York, National Waste Management’s acquisition of Northeast Data Destruction and Recycling comes in response to rising customer demand for cardboard recycling and document destruction, hard drive destruction and other data destruction. The company also expects to leverage its extended reach in the region by offering its existing roll-off services to an expanded client base in the area.
“Acquiring Northeast Data Destruction and Recycling extends our reach to Kingston, New York, allowing us to offer roll-off services as we plan future expansion of this location,” Louis “Tiny” Paveglio, chief executive officer of National Waste Management, added in this morning’s release. “The acquisition enables our sales team to offer the additional services in both locations, and at the same time enables us to trim overhead costs.”
With its latest acquisition now in the books, National Waste Management is primed to continue its recent trend of strong revenue growth. In November, the company released its financial results for the third quarter of 2016, which included a 269 percent year-over-year increase in revenue to $1.7 million. For the first nine months of 2016, National Waste Management’s revenue was up 262 percent over the comparable period of 2015, totaling $4.8 million. Paveglio credited this sustained performance to the “effectiveness” of the company’s acquisition strategy and, in correlation, its “growing customer base.” He went on to call for “continued improvements in profitability” resulting from National Waste Management’s most recent acquisitions, including those of Waste Recovery Enterprises and Gateway Rolloff Services in late 2015, as well as the 2016 acquisition of New York-based Sivart Services.
In an interview with NetworkNewsWire released last month, Paveglio gave prospective investors some additional insight into National Waste Management’s near-term expansion plans. He noted that the company has already identified “a couple acquisitions” for which it is currently performing due diligence, with a goal of completing those transactions during the first two quarters of 2017.
For more information, visit the company’s website at www.nationalwastemgmt.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
“We are proud to announce our final acquisition of 2016, an achievement on par with our goal to become vertically integrated via strategic acquisition,” Dali Kranzthor, chief financial officer of National Waste Management, stated in this morning’s news release. “We have more acquisitions in the pipeline and look forward to another year of building value for National Waste and its shareholders.”
In addition to expanding its base operations in Upstate New York, National Waste Management’s acquisition of Northeast Data Destruction and Recycling comes in response to rising customer demand for cardboard recycling and document destruction, hard drive destruction and other data destruction. The company also expects to leverage its extended reach in the region by offering its existing roll-off services to an expanded client base in the area.
“Acquiring Northeast Data Destruction and Recycling extends our reach to Kingston, New York, allowing us to offer roll-off services as we plan future expansion of this location,” Louis “Tiny” Paveglio, chief executive officer of National Waste Management, added in this morning’s release. “The acquisition enables our sales team to offer the additional services in both locations, and at the same time enables us to trim overhead costs.”
With its latest acquisition now in the books, National Waste Management is primed to continue its recent trend of strong revenue growth. In November, the company released its financial results for the third quarter of 2016, which included a 269 percent year-over-year increase in revenue to $1.7 million. For the first nine months of 2016, National Waste Management’s revenue was up 262 percent over the comparable period of 2015, totaling $4.8 million. Paveglio credited this sustained performance to the “effectiveness” of the company’s acquisition strategy and, in correlation, its “growing customer base.” He went on to call for “continued improvements in profitability” resulting from National Waste Management’s most recent acquisitions, including those of Waste Recovery Enterprises and Gateway Rolloff Services in late 2015, as well as the 2016 acquisition of New York-based Sivart Services.
In an interview with NetworkNewsWire released last month, Paveglio gave prospective investors some additional insight into National Waste Management’s near-term expansion plans. He noted that the company has already identified “a couple acquisitions” for which it is currently performing due diligence, with a goal of completing those transactions during the first two quarters of 2017.
For more information, visit the company’s website at www.nationalwastemgmt.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Friday, January 6, 2017
Monaker Group, Inc. (MKGI) Offers Travelers Real-Time Booking
A shareholder update from Monaker Group, Inc. (OTCQB: MKGI) last month announced the completion of the company’s proprietary booking engine. Reaching this new milestone positions Monaker to offer its customers real-time booking, reducing the uncertainty and anxiety that often plagues making alternative lodging reservations. With its booking engine, Monaker is living up to its motto of Travel Made Easy.
Online travel bookings requiring a booking engine represent, by some accounts, a $340 billion market, as millions of travelers and holidaymakers crisscross the planet. In the early days of aviation, however, there were no frequent flyers, and reservations were usually made by phone. In the late 1940s, after World War II exposed Americans to the wider world, the resulting wanderlust drove passenger volume to levels that overwhelmed that primitive system.
American Airlines was the first to develop an automated booking system. Its esoteric name, ‘Electromechanical Reservisor’ (ER), might have puzzled the average traveler if he were allowed access to it, but he was not. Neither were travel agents. The ER could be accessed only by airline personnel.
By 1953, ER had spawned SABRE, the Semi-Automatic Business Research Environment reservation system. Like ER, this was American Airlines’ baby. Not to be outdone, United Airlines came up with Apollo. Thereafter, acronyms abounded. Delta Airlines launched DATAS. Trans World Airlines responded with PARS. These were all proprietary systems, of course, meant only to be used by the staff of the airline that had developed it.
It wasn’t long before travel agents showed how allowing them access would reduce the cost to airlines by creating less work for airline customer service reps. This gave birth to computer reservation systems (CRS), which travel agents could query and make reservations through.
While a travel agent needed access to different CRS for different airlines, the new Global Distribution Systems (GDS) offered access to the inventory of all the main airlines. The obvious next step for reservation systems was allowing access to customers, which prompted the development of booking engines. Through a booking engine, a would-be traveler can specify his or her travel requirements, such as point of departure, departure date, destination, return date and class of travel. In response, the booking engine will offer airline seats, hotel rooms, alternative accommodation and a variety of related offerings that fit the bill. This was definitely travel made easy.
Now, with the Monaker Booking Engine (MBE), which conforms to all online travel industry standards allowing for easy business-to-business integration, business travel partners and consumers will have real-time access to Monaker’s lodging products.
Monaker has contracted with dozens of lodging vendors and will soon be able to offer some two million rental properties in the U.S., Europe, Asia, South America and the Caribbean. To date, over one million of these properties have been loaded onto its MBE staging servers and the other half are now being certified and will be uploaded soon. Globally, this will give Monaker a meaningful industry presence, emulating sector leaders such as Airbnb, with its 2.5 million properties, and Expedia (NASDAQ: EXPE), with an estimated 1.2 million properties.
Monaker Group is a technology driven travel company with multiple divisions and brands, leveraging more than 60 years of operation in leisure travel. Monaker’s flagship is NextTrip.com, the industry’s first real-time booking engine featuring alternative lodging (vacation home rentals, resort residences and unused timeshares), as well as a vast array of airlines, hotels, cruises, rental cars, tours and concierge services, all combined in one platform to give customers the power of choice when booking their vacations. With key partnerships and established travel brands used as cornerstones, the company’s mission is to continue to expand its offerings in order to become the ‘one stop’ vacation center.
For more information, visit www.MonakerGroup.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Online travel bookings requiring a booking engine represent, by some accounts, a $340 billion market, as millions of travelers and holidaymakers crisscross the planet. In the early days of aviation, however, there were no frequent flyers, and reservations were usually made by phone. In the late 1940s, after World War II exposed Americans to the wider world, the resulting wanderlust drove passenger volume to levels that overwhelmed that primitive system.
American Airlines was the first to develop an automated booking system. Its esoteric name, ‘Electromechanical Reservisor’ (ER), might have puzzled the average traveler if he were allowed access to it, but he was not. Neither were travel agents. The ER could be accessed only by airline personnel.
By 1953, ER had spawned SABRE, the Semi-Automatic Business Research Environment reservation system. Like ER, this was American Airlines’ baby. Not to be outdone, United Airlines came up with Apollo. Thereafter, acronyms abounded. Delta Airlines launched DATAS. Trans World Airlines responded with PARS. These were all proprietary systems, of course, meant only to be used by the staff of the airline that had developed it.
It wasn’t long before travel agents showed how allowing them access would reduce the cost to airlines by creating less work for airline customer service reps. This gave birth to computer reservation systems (CRS), which travel agents could query and make reservations through.
While a travel agent needed access to different CRS for different airlines, the new Global Distribution Systems (GDS) offered access to the inventory of all the main airlines. The obvious next step for reservation systems was allowing access to customers, which prompted the development of booking engines. Through a booking engine, a would-be traveler can specify his or her travel requirements, such as point of departure, departure date, destination, return date and class of travel. In response, the booking engine will offer airline seats, hotel rooms, alternative accommodation and a variety of related offerings that fit the bill. This was definitely travel made easy.
Now, with the Monaker Booking Engine (MBE), which conforms to all online travel industry standards allowing for easy business-to-business integration, business travel partners and consumers will have real-time access to Monaker’s lodging products.
Monaker has contracted with dozens of lodging vendors and will soon be able to offer some two million rental properties in the U.S., Europe, Asia, South America and the Caribbean. To date, over one million of these properties have been loaded onto its MBE staging servers and the other half are now being certified and will be uploaded soon. Globally, this will give Monaker a meaningful industry presence, emulating sector leaders such as Airbnb, with its 2.5 million properties, and Expedia (NASDAQ: EXPE), with an estimated 1.2 million properties.
Monaker Group is a technology driven travel company with multiple divisions and brands, leveraging more than 60 years of operation in leisure travel. Monaker’s flagship is NextTrip.com, the industry’s first real-time booking engine featuring alternative lodging (vacation home rentals, resort residences and unused timeshares), as well as a vast array of airlines, hotels, cruises, rental cars, tours and concierge services, all combined in one platform to give customers the power of choice when booking their vacations. With key partnerships and established travel brands used as cornerstones, the company’s mission is to continue to expand its offerings in order to become the ‘one stop’ vacation center.
For more information, visit www.MonakerGroup.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Bovie Medical Corporation (BVX) CEO to Present at Biotech Showcase 2017
Earlier this week, Bovie Medical Corporation (NYSE MKT: BVX), a leading developer of medical devices and supplies, announced its plans to participate in the 9th Annual Biotech Showcase Conference, which is set to take place at the Hilton San Francisco Union Square from January 9-11. Robert L. Gershon, the company’s chief executive officer, is scheduled to present to investors at 11:00 am PST on Tuesday, January 10. Planned talking points include Bovie Medical’s recent activities, as well as the company’s innovative J-Plasma® surgical instrument. Additionally, Gershon is expected to present at Medtech Showcase at the Parc 55 San Francisco Hotel in Union Square on Wednesday, January 11 at 10:30 am PST.
To learn more about Biotech Showcase 2017, visit http://nnw.fm/I1blo
Bovie Medical – named for the inventor of modern electrosurgery, Dr. William T. Bovie – leverages a portfolio of proprietary technology and expertise spanning the design, development and manufacture of electrosurgical equipment to create advanced energy devices that it markets around the globe. The company maintains a number of well-respected brands, including Bovie®, Aaron®, IDS™ and ICON™, in addition to marketing its products through private labels.
J-Plasma® is Bovie Medical’s leading product. A plasma-based surgical product for cutting and coagulation, J-Plasma® combines the unique properties of cold helium plasma with RF energy to give surgeons greater precision, minimal invasiveness and an absence of potentially dangerous conductive currents through patients during surgery. To date, the product has been used successfully in a wide array of surgical procedures, such as capsular scoring, wound debridement and scar revision. J-Plasma® is still in the early stages of commercialization, according to the company’s website, but Bovie Medical believes that it has the potential to become a “transformational product for surgeons.”
In August 2016, the market potential of J-Plasma® was reaffirmed when a portion of the J-Plasma® platform was recognized as an “Innovation of the Year” by The Society of Laparoendoscopic Surgeons for the third consecutive year. The Precise 360™ hand piece, which received this year’s distinction, features an angled and rotating tip that allows surgeons to access structures that are difficult to reach with a straight laparoscopic device. In 2014, the J-Plasma® product line received the same distinction, and, in 2015, the title was given to the Bovie Ultimate™ Operating Room Generator, which combines J-Plasma® technology with the highest wattage monopolar and bipolar electrosurgical generator.
For more information, visit www.BovieMedical.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
To learn more about Biotech Showcase 2017, visit http://nnw.fm/I1blo
Bovie Medical – named for the inventor of modern electrosurgery, Dr. William T. Bovie – leverages a portfolio of proprietary technology and expertise spanning the design, development and manufacture of electrosurgical equipment to create advanced energy devices that it markets around the globe. The company maintains a number of well-respected brands, including Bovie®, Aaron®, IDS™ and ICON™, in addition to marketing its products through private labels.
J-Plasma® is Bovie Medical’s leading product. A plasma-based surgical product for cutting and coagulation, J-Plasma® combines the unique properties of cold helium plasma with RF energy to give surgeons greater precision, minimal invasiveness and an absence of potentially dangerous conductive currents through patients during surgery. To date, the product has been used successfully in a wide array of surgical procedures, such as capsular scoring, wound debridement and scar revision. J-Plasma® is still in the early stages of commercialization, according to the company’s website, but Bovie Medical believes that it has the potential to become a “transformational product for surgeons.”
In August 2016, the market potential of J-Plasma® was reaffirmed when a portion of the J-Plasma® platform was recognized as an “Innovation of the Year” by The Society of Laparoendoscopic Surgeons for the third consecutive year. The Precise 360™ hand piece, which received this year’s distinction, features an angled and rotating tip that allows surgeons to access structures that are difficult to reach with a straight laparoscopic device. In 2014, the J-Plasma® product line received the same distinction, and, in 2015, the title was given to the Bovie Ultimate™ Operating Room Generator, which combines J-Plasma® technology with the highest wattage monopolar and bipolar electrosurgical generator.
For more information, visit www.BovieMedical.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Thursday, January 5, 2017
Monaker Group, Inc. (MKGI) Secures Independent Majority with Addition of Simon Orange to Board of Directors
Before the opening bell, Monaker Group, Inc. (OTCQB: MKGI) announced the appointment of Simon Orange, the founding partner and chairman of CorpAcq, to its board of directors. In addition to adding extensive investment industry knowledge and experience to the Monaker team, Orange’s appointment also advances the company’s long-term goal of uplisting to the Nasdaq Capital Market. With this appointment, Monaker Group’s board of directors now includes five members, including three who are serving independently. Nasdaq corporate governance requirements specify that independent members must make up the majority of the board of directors for nearly all listed companies.
“While Simon’s appointment satisfies the listing requirements for an independent majority, we are continuing our search and evaluation process to bring on additional board members who will strengthen our leadership and composition of our board committees,” Bill Kerby, chairman and chief executive officer of Monaker Group, stated in this morning’s news release. “We expect to announce such additional appointments in the near term.”
Moving forward, Orange is expected to play a key role in the expansion of Monaker Group’s foothold in the global travel industry. In 2006, he co-founded CorpAcq, a UK-based corporate acquisitions and investments firm with a portfolio that currently includes 19 companies. Recognized as one of the fastest growing enterprises in the United Kingdom, CorpAcq has played a key role in the funding and management of numerous business ventures, many of which have been acquired by sizable Nasdaq and London Stock Exchange listed companies. In addition to his work with CorpAcq, Orange is also a founding member of New York-based Cicero Consulting Group.
“I have long been passionate about travel, and intrigued with how technology continues to transform the hospitality and travel landscape,” Orange noted in this morning’s release. “I’m honored and excited to join the Monaker board and leadership teams, particularly at this pivotal stage of the company’s development, with the near-term launch of its unique booking platform that for the first time will provide ‘real-time’ alternative lodging reservations along with mainstream travel products and services all on a single site.”
As noted in a December update, Monaker Group is currently working toward the launch of its alternative lodging rental (ALR) business later this month. This innovative offering will feature two components, including the company’s proprietary Monaker Booking Engine (MBE) and its flagship NextTrip.com platform. The MBE will allow both business travel partners and consumers to access Monaker Group’s expansive portfolio of lodging products, which currently features well over one million properties in the United States, Europe, Asia, South America and the Caribbean. On the other hand, NextTrip.com will continue to serve as a direct-to-consumer platform by offering, for the first time, real-time ALR reservations alongside major mainstream travel products and services.
For more information, visit www.MonakerGroup.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
“While Simon’s appointment satisfies the listing requirements for an independent majority, we are continuing our search and evaluation process to bring on additional board members who will strengthen our leadership and composition of our board committees,” Bill Kerby, chairman and chief executive officer of Monaker Group, stated in this morning’s news release. “We expect to announce such additional appointments in the near term.”
Moving forward, Orange is expected to play a key role in the expansion of Monaker Group’s foothold in the global travel industry. In 2006, he co-founded CorpAcq, a UK-based corporate acquisitions and investments firm with a portfolio that currently includes 19 companies. Recognized as one of the fastest growing enterprises in the United Kingdom, CorpAcq has played a key role in the funding and management of numerous business ventures, many of which have been acquired by sizable Nasdaq and London Stock Exchange listed companies. In addition to his work with CorpAcq, Orange is also a founding member of New York-based Cicero Consulting Group.
“I have long been passionate about travel, and intrigued with how technology continues to transform the hospitality and travel landscape,” Orange noted in this morning’s release. “I’m honored and excited to join the Monaker board and leadership teams, particularly at this pivotal stage of the company’s development, with the near-term launch of its unique booking platform that for the first time will provide ‘real-time’ alternative lodging reservations along with mainstream travel products and services all on a single site.”
As noted in a December update, Monaker Group is currently working toward the launch of its alternative lodging rental (ALR) business later this month. This innovative offering will feature two components, including the company’s proprietary Monaker Booking Engine (MBE) and its flagship NextTrip.com platform. The MBE will allow both business travel partners and consumers to access Monaker Group’s expansive portfolio of lodging products, which currently features well over one million properties in the United States, Europe, Asia, South America and the Caribbean. On the other hand, NextTrip.com will continue to serve as a direct-to-consumer platform by offering, for the first time, real-time ALR reservations alongside major mainstream travel products and services.
For more information, visit www.MonakerGroup.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
Subscribe to:
Posts (Atom)